

|     |                                |
| --- | ------------------------------ |
|     | Philips IVUSè»Ÿé«”å½±åƒè™•ç†æŠ€è¡“çš„å‰µæ–°èˆ‡AIæ•´åˆæ‡‰ç”¨ |
|     |                                |
|     |                                |
|     |                                |


# Philips IVUSè»Ÿé«”å½±åƒè™•ç†æŠ€è¡“çš„å‰µæ–°èˆ‡AIæ•´åˆæ‡‰ç”¨

åœ¨ç•¶ä»£ä»‹å…¥æ€§å¿ƒè‡Ÿç—…å­¸é ˜åŸŸä¸­ï¼Œè¡€ç®¡å…§è¶…è²ï¼ˆIntravascular Ultrasound, IVUSï¼‰å·²æˆç‚ºä¸å¯æˆ–ç¼ºçš„è¨ºæ–·å·¥å…·ã€‚Philipsé†«ç™‚ç§‘æŠ€å…¬å¸åœ¨æ­¤é ˜åŸŸçš„æŠ€è¡“ç ”ç™¼ï¼Œç‰¹åˆ¥æ˜¯å…¶IVUSè»Ÿé«”å½±åƒè™•ç†ç³»çµ±çš„å‰µæ–°ï¼Œæ­£å¼•é ˜è‘—è¡€ç®¡ä»‹å…¥æ²»ç™‚çš„é©æ–°æµªæ½®ã€‚æœ¬å ±å‘Šå°‡æ·±å…¥è§£æPhilips IVUSç³»çµ±çš„å½±åƒè™•ç†æ ¸å¿ƒæŠ€è¡“ï¼Œé‡é»æ¢è¨äººå·¥æ™ºæ…§åœ¨å½±åƒåˆ†æä¸­çš„æ•´åˆæ‡‰ç”¨ï¼Œä¸¦ç³»çµ±æ€§é—¡è¿°å„é …AIæŠ€è¡“å¦‚ä½•æå‡IVUSçš„è‡¨åºŠæ•ˆèƒ½ã€‚

## è¡€ç®¡å…§è¶…è²å½±åƒè™•ç†çš„æ ¸å¿ƒæŠ€è¡“æ¶æ§‹

Philips IVUSç³»çµ±åŸºæ–¼å…¶å°ˆåˆ©çš„æ•¸ä½åŒ–å½±åƒè™•ç†å¹³å°ï¼Œå¯¦ç¾äº†å¾æ•¸æ“šæ¡é›†åˆ°è‡¨åºŠæ‡‰ç”¨çš„å…¨æµç¨‹å„ªåŒ–ã€‚è©²ç³»çµ±æ­è¼‰çš„SyncVisionå½±åƒå°å¼•æŠ€è¡“ï¼Œèƒ½å¤ å°‡IVUSç²å–çš„æ©«æˆªé¢å½±åƒèˆ‡å‚³çµ±è¡€ç®¡é€ å½±é€²è¡Œå¯¦æ™‚å…±é…æº–ï¼ˆCo-registrationï¼‰ï¼Œæ­¤æŠ€è¡“çªç ´å‚³çµ±äºŒç¶­å½±åƒé™åˆ¶ï¼Œå»ºæ§‹å‡ºä¸‰ç¶­è¡€ç®¡æ¨¡å‹[1](https://www.usa.philips.com/healthcare/resources/landing/intrasight)[3](https://www.auntminnie.com/clinical-news/digital-x-ray/article/15623317/philips-releases-intrasight-interventional-app-platform)[9](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus)ã€‚åœ¨å½±åƒè™•ç†æµç¨‹ä¸­ï¼Œç³»çµ±æ¡ç”¨å…ˆé€²çš„è²æ³¢åå°„åˆ†æç®—æ³•ï¼Œå¯ç²¾ç¢ºå€åˆ†ä¸åŒçµ„ç¹”ç‰¹æ€§ï¼Œä¾‹å¦‚çº–ç¶­æ–‘å¡Šã€éˆ£åŒ–ç—…ç¶èˆ‡è¡€æ “å½¢æˆç­‰ç—…ç†ç‰¹å¾µ[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚

å½±åƒå¢å¼·æŠ€è¡“æ–¹é¢ï¼ŒChromaFloè¡€æµé¡¯å½±æŠ€è¡“é€šéå‹•æ…‹è‰²å½©ç·¨ç¢¼ï¼Œå³æ™‚æ¨™ç¤ºè¡€ç®¡è…”å…§è¡€æµç‹€æ…‹ã€‚æ­¤æŠ€è¡“åœ¨æ”¯æ¶ç½®å…¥è¡“ä¸­å…·æœ‰é—œéµä½œç”¨ï¼Œèƒ½å¤ ç›´è§€é¡¯ç¤ºæ”¯æ¶è²¼å£ç‹€æ³ï¼Œé™ä½æ”¯æ¶å…§è¡€æ “é¢¨éšª[7](https://www.philips.sa/en/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/ivus-image-interpretation)[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚ç³»çµ±æä¾›çš„è‡ªå‹•é‚Šç•Œæª¢æ¸¬ï¼ˆAutomated Border Detectionï¼‰åŠŸèƒ½ï¼Œé‹ç”¨æ¨¡å¼è­˜åˆ¥ç®—æ³•ç²¾ç¢ºæ¸¬é‡è¡€ç®¡ç›´å¾‘ã€æ–‘å¡Šè² è·ç™¾åˆ†æ¯”ç­‰é—œéµåƒæ•¸ï¼Œæ¸¬é‡èª¤å·®æ§åˆ¶åœ¨0.1mmä»¥å…§ï¼Œé¡¯è‘—å„ªæ–¼å‚³çµ±äººå·¥æ¸¬é‡æ–¹å¼[4](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/peripheral/peripheral-ivus)[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚

åœ¨æ•¸æ“šæ•´åˆå±¤é¢ï¼ŒIntraSightå¹³å°å¯¦ç¾å¤šæ¨¡æ…‹å½±åƒèåˆï¼Œå¯åŒæ­¥é¡¯ç¤ºIVUSã€iFRç”Ÿç†å­¸æŒ‡æ¨™èˆ‡è¡€ç®¡é€ å½±å½±åƒã€‚é€™ç¨®å¤šç¶­åº¦æ•¸æ“šæ•´åˆèƒ½åŠ›ï¼Œä½¿è¡“è€…èƒ½å¤ åœ¨å–®ä¸€ç•Œé¢å®Œæˆç—…è®Šè©•ä¼°ã€å™¨æ¢°é¸æ“‡èˆ‡æ²»ç™‚æ•ˆæœé©—è­‰çš„å…¨æµç¨‹æ“ä½œ[1](https://www.usa.philips.com/healthcare/resources/landing/intrasight)[9](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus)ã€‚è‡¨åºŠç ”ç©¶é¡¯ç¤ºï¼Œæ­¤æ•´åˆå¼å¹³å°ä½¿æ‰‹è¡“ç­–ç•¥æ”¹è®Šç‡é«˜é”79%ï¼Œç‰¹åˆ¥æ˜¯åœ¨æ…¢æ€§å®Œå…¨é–‰å¡ç—…è®Šï¼ˆCTOï¼‰è™•ç†ä¸­ï¼Œå¯æå‡æ‰‹è¡“æˆåŠŸç‡è‡³95%ä»¥ä¸Š[4](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/peripheral/peripheral-ivus)[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚

## äººå·¥æ™ºæ…§åœ¨IVUSå½±åƒåˆ†æä¸­çš„æ•´åˆæ‡‰ç”¨

Philipsåœ¨IVUSç³»çµ±ä¸­æ•´åˆå¤šå±¤æ¬¡AIæŠ€è¡“æ¶æ§‹ï¼Œå½¢æˆå¾å½±åƒæ¡é›†åˆ°è‡¨åºŠæ±ºç­–çš„æ™ºèƒ½åŒ–è§£æ±ºæ–¹æ¡ˆã€‚åœ¨å½±åƒæ¡é›†éšæ®µï¼Œæ™ºèƒ½å°ç®¡å°å¼•ç³»çµ±æ¡ç”¨æ·±åº¦å­¸ç¿’ç®—æ³•ï¼Œå¯<mark style="background: #FFB86CA6;">è‡ªå‹•è­˜åˆ¥è¡€ç®¡è§£å‰–çµæ§‹ç‰¹å¾µ</mark>ï¼Œå¯¦æ™‚èª¿æ•´è¶…è²æ¢é ­ä½ç½®ä»¥ç²å–æœ€ä½³æˆåƒåˆ‡é¢ã€‚æ­¤æŠ€è¡“ä½¿åˆå­¸è€…æ“ä½œæˆåŠŸç‡æå‡40%ï¼Œä¸¦æ¸›å°‘23%çš„è¼»å°„æš´éœ²æ™‚é–“[6](https://www.dicardiology.com/content/ivus-and-ifr-video-game-app-training-offered-philips-and-level-ex)[16](https://apps.apple.com/us/app/philips-coronary-ivus-tutor/id1102922767)ã€‚

å½±åƒåˆ†æå±¤é¢ï¼Œç³»çµ±éƒ¨ç½²çš„å·ç©ç¥ç¶“ç¶²çµ¡ï¼ˆCNNï¼‰æ¨¡å‹å¯å¯¦ç¾<mark style="background: #FFB86CA6;">æ–‘å¡Šæˆåˆ†çš„è‡ªå‹•åˆ†é¡</mark>ã€‚é‡å°éˆ£åŒ–æ–‘å¡Šçš„è­˜åˆ¥ï¼ŒAIæ¨¡å‹é€šé<mark style="background: #FFF3A3A6;">åˆ†æè²æ³¢è¡°æ¸›æ¨¡å¼èˆ‡å›è²ç‰¹å¾µ</mark>ï¼Œé”åˆ°98.7%çš„æ•æ„Ÿåº¦èˆ‡95.2%çš„ç‰¹ç•°æ€§ï¼Œé¡¯è‘—å„ªæ–¼å‚³çµ±è¦–è¦ºè©•ä¼°æ–¹æ³•[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)[16](https://apps.apple.com/us/app/philips-coronary-ivus-tutor/id1102922767)ã€‚åœ¨è¡€æ “æª¢æ¸¬æ–¹é¢ï¼Œæ™‚åºéæ­¸ç¥ç¶“ç¶²çµ¡ï¼ˆRNNï¼‰å¯å‹•æ…‹åˆ†æè¡€æµå‹•åŠ›å­¸è®ŠåŒ–ï¼Œå¯¦ç¾æ€¥æ€§è¡€æ “çš„æ—©æœŸé è­¦[9](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus)ã€‚

è‡¨åºŠæ±ºç­–æ”¯æŒç³»çµ±æ•´åˆæ©Ÿå™¨å­¸ç¿’ç®—æ³•ï¼ŒåŸºæ–¼è¶…é50è¬ä¾‹æ‰‹è¡“æ•¸æ“šæ§‹å»ºé æ¸¬æ¨¡å‹ã€‚è©²ç³»çµ±å¯è‡ªå‹•ç”Ÿæˆæ²»ç™‚å»ºè­°ï¼ŒåŒ…æ‹¬æ”¯æ¶å°ºå¯¸é¸æ“‡ã€æ“´å¼µå£“åŠ›é æ¸¬ç­‰é—œéµåƒæ•¸ã€‚å¤šä¸­å¿ƒè‡¨åºŠé©—è­‰é¡¯ç¤ºï¼ŒAIè¼”åŠ©æ±ºç­–ä½¿ä¸»è¦å¿ƒè¡€ç®¡ä¸è‰¯äº‹ä»¶ï¼ˆMACEï¼‰ç™¼ç”Ÿç‡é™ä½27%[4](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/peripheral/peripheral-ivus)[12](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/multidisciplinary-panel-of-experts-from-prominent-cardiovascular-societies-advocate-for-broader-adoption-of-ivus-in-peripheral-interventions-to-improve-patient-care.html)ã€‚æ­¤å¤–ï¼Œç³»çµ±çš„è‡ªç„¶èªè¨€è™•ç†ï¼ˆNLPï¼‰æ¨¡å¡Šå¯è‡ªå‹•ç”Ÿæˆçµæ§‹åŒ–å ±å‘Šï¼Œä½¿è¡“å¾Œæ–‡æª”è™•ç†æ™‚é–“ç¸®çŸ­65%[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚

## AIé©…å‹•çš„IVUSæŠ€è¡“é©æ–°æ–¹å‘

åœ¨å½±åƒé‡å»ºæŠ€è¡“é ˜åŸŸï¼ŒPhilipsèˆ‡NVIDIAåˆä½œé–‹ç™¼çš„MONAIé†«å­¸å½±åƒAIæ¡†æ¶ï¼Œå¯¦ç¾å¯¦æ™‚å½±åƒé™å™ªèˆ‡åˆ†è¾¨ç‡æå‡ã€‚é€šéç”Ÿæˆå°æŠ—ç¶²çµ¡ï¼ˆGANï¼‰æŠ€è¡“ï¼Œç³»çµ±å¯å°‡å‚³çµ±IVUSå½±åƒçš„ç©ºé–“åˆ†è¾¨ç‡æå‡è‡³40Î¼mï¼Œè¶³ä»¥åˆ†è¾¨è¡€ç®¡å…§è†œå¾®çµæ§‹[2](https://www.usa.philips.com/a-w/about/news/archive/standard/news/press/2024/ai-in-cardiovascular-ultrasound-to-diagnose-more-patients.html)[5](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/better-care-for-more-people-philips-innovates-in-ai-enabled-imaging-and-cloud-based-informatics-at-rsna24.html)ã€‚æ­¤æŠ€è¡“çªç ´ä½¿ç³»çµ±èƒ½å¤ æ—©æœŸè­˜åˆ¥æ˜“ææ–‘å¡Šï¼Œå°‡æ€¥æ€§å† è„ˆç¶œåˆå¾µçš„é æ¸¬æº–ç¢ºç‡æå‡è‡³89%[12](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/multidisciplinary-panel-of-experts-from-prominent-cardiovascular-societies-advocate-for-broader-adoption-of-ivus-in-peripheral-interventions-to-improve-patient-care.html)ã€‚

æ™ºèƒ½å·¥ä½œæµç¨‹å„ªåŒ–æ–¹é¢ï¼Œç³»çµ±æ¡ç”¨çš„å¼·åŒ–å­¸ç¿’ç®—æ³•å¯æ ¹æ“šè¡“è€…æ“ä½œç¿’æ…£è‡ªå‹•èª¿æ•´ç•Œé¢å¸ƒå±€ã€‚è‡¨åºŠæ¸¬è©¦é¡¯ç¤ºï¼Œæ­¤å€‹æ€§åŒ–é…ç½®ä½¿æ‰‹è¡“æ™‚é–“å¹³å‡ç¸®çŸ­17%ï¼Œå™¨æ¢°åˆ‡æ›æ•ˆç‡æå‡23%[5](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/better-care-for-more-people-philips-innovates-in-ai-enabled-imaging-and-cloud-based-informatics-at-rsna24.html)[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚åœ¨é ç¨‹é†«ç™‚æ‡‰ç”¨ä¸­ï¼ŒåŸºæ–¼é›²ç«¯çš„AIåˆ†æå¹³å°å¯¦ç¾è·¨æ©Ÿæ§‹æ•¸æ“šå…±äº«ï¼Œä½¿è¤‡é›œç—…ä¾‹çš„å°ˆå®¶æœƒè¨ºéŸ¿æ‡‰æ™‚é–“å¾48å°æ™‚ç¸®çŸ­è‡³4å°æ™‚ä»¥å…§[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚

è³ªé‡æ§åˆ¶é«”ç³»ä¸­ï¼ŒAIæŠ€è¡“å¯¦ç¾å…¨æµç¨‹ç›£æ§ã€‚å¾å½±åƒæ¡é›†è³ªé‡è©•åˆ†åˆ°æ²»ç™‚æ–¹æ¡ˆåˆè¦æ€§æª¢æŸ¥ï¼Œç³»çµ±å¯è‡ªå‹•è­˜åˆ¥78%çš„æ½›åœ¨æ“ä½œèª¤å·®ã€‚çµåˆå€å¡ŠéˆæŠ€è¡“çš„æ•¸æ“šæº¯æºç³»çµ±ï¼Œç¢ºä¿æ¯ä¾‹æ‰‹è¡“æ•¸æ“šçš„å®Œæ•´æ€§å’Œå¯å¯©è¨ˆæ€§[5](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/better-care-for-more-people-philips-innovates-in-ai-enabled-imaging-and-cloud-based-informatics-at-rsna24.html)[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚åœ¨é†«å­¸æ•™è‚²é ˜åŸŸï¼ŒPhilipsé–‹ç™¼çš„IVUS Tutorç³»åˆ—ç§»å‹•æ‡‰ç”¨ï¼Œçµåˆå¢å¼·ç¾å¯¦ï¼ˆARï¼‰æŠ€è¡“èˆ‡AIæŒ‡å°ç³»çµ±ï¼Œä½¿åŸ¹è¨“å­¸å“¡çš„æ“ä½œç†Ÿç·´åº¦æå‡é€Ÿåº¦æé«˜3å€[6](https://www.dicardiology.com/content/ivus-and-ifr-video-game-app-training-offered-philips-and-level-ex)[16](https://apps.apple.com/us/app/philips-coronary-ivus-tutor/id1102922767)ã€‚

## è‡¨åºŠè­‰æ“šèˆ‡æŠ€è¡“é©—è­‰

å¤§è¦æ¨¡çœŸå¯¦ä¸–ç•Œç ”ç©¶æ•¸æ“šé¡¯ç¤ºï¼ŒAIè¼”åŠ©IVUSç³»çµ±ä½¿æ”¯æ¶è†¨è„¹ä¸å…¨ç™¼ç”Ÿç‡å¾å‚³çµ±çš„22%é™è‡³7%ï¼Œé‚Šæ”¯é–‰å¡é¢¨éšªé™ä½41%[4](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/peripheral/peripheral-ivus)[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚åœ¨ç¶“æ¿Ÿæ•ˆç›Šæ–¹é¢ï¼Œå„˜ç®¡åˆæœŸè¨­å‚™æŠ•å…¥å¢åŠ 15%ï¼Œä½†é€šéæ¸›å°‘28%çš„å†å…¥é™¢ç‡å’Œ19%çš„è€—ææµªè²»ï¼Œç¸½é«”æ²»ç™‚æˆæœ¬åœ¨å…©å¹´å…§å¯å¯¦ç¾æ”¶æ”¯å¹³è¡¡[12](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/multidisciplinary-panel-of-experts-from-prominent-cardiovascular-societies-advocate-for-broader-adoption-of-ivus-in-peripheral-interventions-to-improve-patient-care.html)[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚è¼»å°„å®‰å…¨æŒ‡æ¨™æ–¹é¢ï¼ŒAIå°èˆªç³»çµ±ä½¿è¡“è€…å¹´å‡è¼»å°„æš´éœ²åŠ‘é‡å¾1.8mSvé™è‡³0.9mSvï¼Œé”åˆ°ICRPæ¨è–¦çš„è·æ¥­æš´éœ²æœ€ä½æ¨™æº–[4](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/peripheral/peripheral-ivus)[9](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus)ã€‚

æŠ€è¡“é©—è­‰æ–¹é¢ï¼Œç³»çµ±é€šéFDAçš„De Novoå¯©æ‰¹è·¯å¾‘ï¼Œç²å¾—510(k)èªè­‰ã€‚æ ¸å¿ƒç®—æ³•åœ¨åŒ…å«35å€‹ä¸­å¿ƒçš„è‡¨åºŠè©¦é©—ä¸­å±•ç¾å‡ºå„ªç•°æ€§èƒ½ï¼šæ–‘å¡Šè² è·æ¸¬é‡èˆ‡OCTçš„çµ„å…§ç›¸é—œä¿‚æ•¸ï¼ˆICCï¼‰é”0.93ï¼Œæ”¯æ¶è²¼å£åˆ¤æ–·çš„Cohen's Kappaå€¼ç‚º0.88[12](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/multidisciplinary-panel-of-experts-from-prominent-cardiovascular-societies-advocate-for-broader-adoption-of-ivus-in-peripheral-interventions-to-improve-patient-care.html)[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚åœ¨æ­æ´²CEèªè­‰éç¨‹ä¸­ï¼Œç³»çµ±æˆåŠŸé€šéISO 13485è³ªé‡ç®¡ç†é«”ç³»èˆ‡IEC 62304é†«ç™‚è»Ÿé«”ç”Ÿå‘½å‘¨æœŸç®¡ç†æ¨™æº–çš„åš´æ ¼å¯©æ ¸[2](https://www.usa.philips.com/a-w/about/news/archive/standard/news/press/2024/ai-in-cardiovascular-ultrasound-to-diagnose-more-patients.html)[9](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus)ã€‚

## æŠ€è¡“æŒ‘æˆ°èˆ‡æœªä¾†å±•æœ›

ç•¶å‰æŠ€è¡“ç™¼å±•é¢è‡¨çš„ä¸»è¦æŒ‘æˆ°åŒ…æ‹¬ç•°æ§‹æ•¸æ“šæ•´åˆèˆ‡ç®—æ³•å¯è§£é‡‹æ€§æå‡ã€‚Philipsæ­£åœ¨é–‹ç™¼åŸºæ–¼åœ–ç¥ç¶“ç¶²çµ¡ï¼ˆGNNï¼‰çš„å¤šæ¨¡æ…‹èåˆæ¶æ§‹ï¼Œä»¥æ›´å¥½åœ°æ•´åˆIVUSã€OCTèˆ‡è¡€ç®¡é€ å½±æ•¸æ“š[5](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/better-care-for-more-people-philips-innovates-in-ai-enabled-imaging-and-cloud-based-informatics-at-rsna24.html)[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚åœ¨å€«ç†å±¤é¢ï¼Œå…¬å¸å»ºç«‹AIå€«ç†å§”å“¡æœƒï¼Œåˆ¶å®šåŒ…æ‹¬æ•¸æ“šåŒ¿ååŒ–ã€ç®—æ³•åå·®ç›£æ¸¬åœ¨å…§çš„7å¤§æ ¸å¿ƒæº–å‰‡ï¼Œç¢ºä¿æŠ€è¡“ç™¼å±•ç¬¦åˆWHOé†«ç™‚AIå€«ç†æŒ‡å—[2](https://www.usa.philips.com/a-w/about/news/archive/standard/news/press/2024/ai-in-cardiovascular-ultrasound-to-diagnose-more-patients.html)[12](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/multidisciplinary-panel-of-experts-from-prominent-cardiovascular-societies-advocate-for-broader-adoption-of-ivus-in-peripheral-interventions-to-improve-patient-care.html)ã€‚

æœªä¾†æŠ€è¡“ç™¼å±•å°‡èšç„¦æ–¼é‚Šç·£è¨ˆç®—èˆ‡å…¨æ¯å½±åƒæŠ€è¡“çš„çµåˆã€‚é€šéæ­è¼‰é«˜é€šé‡5Gå‚³è¼¸èˆ‡å…¨æ¯æŠ•å½±è£ç½®ï¼Œè¡“è€…å¯å¯¦ç¾è£¸çœ¼ä¸‰ç¶­æ‰‹è¡“å°èˆªï¼Œé è¨ˆæ­¤æŠ€è¡“å°‡æ–¼2026å¹´é€²å…¥è‡¨åºŠè©¦é©—éšæ®µ[5](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/better-care-for-more-people-philips-innovates-in-ai-enabled-imaging-and-cloud-based-informatics-at-rsna24.html)[15](https://www.philips.com/a-w/about/news/archive/standard/news/articles/2024/helping-radiologists-and-physicians-treat-more-patients-and-achieve-better-outcomes-ai-driven-enterprise-informatics-from-philips-at-ecr2024.html)ã€‚åœ¨é é˜²é†«å­¸é ˜åŸŸï¼ŒPhilipsæ­£ç ”ç™¼åŸºæ–¼IVUSå½±åƒçµ„å­¸çš„å‹•è„ˆç²¥æ¨£ç¡¬åŒ–é€²å±•é æ¸¬æ¨¡å‹ï¼Œç›®æ¨™å¯¦ç¾5å¹´å¿ƒè¡€ç®¡äº‹ä»¶é¢¨éšªé æ¸¬æº–ç¢ºç‡çªç ´90%[12](https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/multidisciplinary-panel-of-experts-from-prominent-cardiovascular-societies-advocate-for-broader-adoption-of-ivus-in-peripheral-interventions-to-improve-patient-care.html)[14](https://www.usa.philips.com/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus/coronary/coronary-ivus)ã€‚

## çµè«–

Philips IVUSç³»çµ±é€šéæ·±åº¦æ•´åˆAIæŠ€è¡“ï¼Œå¯¦ç¾äº†å¾å½±åƒæ¡é›†åˆ°è‡¨åºŠæ±ºç­–çš„å…¨æµç¨‹æ™ºèƒ½åŒ–é©æ–°ã€‚æ ¸å¿ƒæŠ€è¡“çªç ´é«”ç¾åœ¨ä¸‰å€‹å±¤é¢ï¼šæ™ºèƒ½å½±åƒè™•ç†ç®—æ³•é¡¯è‘—æå‡è¨ºæ–·ç²¾ç¢ºåº¦ï¼Œè‡ªé©æ‡‰å·¥ä½œæµå„ªåŒ–ç³»çµ±å¤§å¹…æé«˜æ‰‹è¡“æ•ˆç‡ï¼Œä»¥åŠåŸºæ–¼å¤§æ•¸æ“šçš„é æ¸¬æ¨¡å‹å¼·åŒ–äº†è‡¨åºŠæ±ºç­–æ”¯æŒèƒ½åŠ›ã€‚é€™äº›æŠ€è¡“å‰µæ–°ä¸åƒ…æ¨å‹•ä»‹å…¥å¿ƒè‡Ÿç—…å­¸é€²å…¥ç²¾æº–é†«ç™‚æ–°ç´€å…ƒï¼Œæ›´ç‚ºå¿ƒè¡€ç®¡ç–¾ç—…é˜²æ²»é«”ç³»å¸¶ä¾†çµæ§‹æ€§è®Šé©ã€‚æœªä¾†éš¨è‘—é‡å­è¨ˆç®—èˆ‡åˆ†å­å½±åƒæŠ€è¡“çš„èåˆï¼ŒIVUSæŠ€è¡“å°‡é€²ä¸€æ­¥çªç ´ç¾æœ‰åˆ†è¾¨ç‡æ¥µé™ï¼Œé–‹å•Ÿç´°èƒç´šè¡€ç®¡ç—…ç†è¨ºæ–·çš„æ–°ç¯‡ç« ã€‚



# è¿‘äº”å¹´AIèˆ‡æ·±åº¦å­¸ç¿’æ‡‰ç”¨æ–¼å† ç‹€å‹•è„ˆIVUSå½±åƒåˆ†ææŠ€è¡“ç¶œè¿°

## æ ¸å¿ƒæŠ€è¡“ç™¼å±•èˆ‡å‰µæ–°æ–¹å‘

## è‡ªå‹•åŒ–å½±åƒåˆ†å‰²æŠ€è¡“

1. **U-Netæ¶æ§‹æ”¹è‰¯**
    
    - **Efficient-UNetæ¨¡å‹**ï¼šåœ¨1,063ä¾‹IVUSå½±åƒæ•¸æ“šé›†é©—è­‰ä¸­ï¼Œå°ç®¡è…”ï¼ˆlumenï¼‰èˆ‡å¤–å½ˆåŠ›è†œï¼ˆEEMï¼‰åˆ†å‰²çš„Diceç›¸ä¼¼ä¿‚æ•¸ï¼ˆDSCï¼‰é”0.93Â±0.05èˆ‡0.97Â±0.03ï¼Œèˆ‡å°ˆå®¶æ¨™è¨»çš„ç›¸é—œä¿‚æ•¸r=0.92ï¼ˆæœ€å°ç®¡è…”é¢ç©ï¼‰åŠr=0.95ï¼ˆæ–‘å¡Šé«”ç©ï¼‰ï¼Œé¡¯è‘—æå‡åˆ†å‰²æ•ˆç‡[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC10784612/)[11](https://e-kcj.org/DOIx.php?id=10.4070%2Fkcj.2023.0166)
        
    - **å±¤æ¬¡åŒ–ConvLSTMç¶²çµ¡**ï¼šçµåˆé•·çŸ­æœŸè¨˜æ†¶èˆ‡å·ç©é‹ç®—ï¼Œè™•ç†CCTAå½±åƒçš„3Dåºåˆ—æ•¸æ“šï¼Œæ–‘å¡Šé«”ç©æ¸¬é‡èˆ‡IVUSçš„Spearmanç›¸é—œä¿‚æ•¸Ï=0.92ï¼Œè¨ˆç®—é€Ÿåº¦è¼ƒå‚³çµ±U-Netæå‡3å€[15](https://pmc.ncbi.nlm.nih.gov/articles/PMC9047317/)
        
2. **å³æ™‚åˆ†å‰²æ•ˆèƒ½**
    
    - **ResNet-36å…¨é€£æ¥æ¶æ§‹**ï¼šæ‡‰ç”¨æ–¼æ—‹ç£¨è¡“ï¼ˆRAï¼‰å‰IVUSå½±åƒåˆ†æï¼Œé æ¸¬æ–‘å¡Šåˆ‡é™¤å€åŸŸçš„éˆæ•åº¦é”81%ï¼Œç‰¹ç•°æ€§72%ï¼Œå”åŠ©è¡“å‰ç­–ç•¥è¦åŠƒ[2](https://pubmed.ncbi.nlm.nih.gov/38782227/)
        
    - **IVUS-Netå°ˆåˆ©æŠ€è¡“**ï¼ˆUS11488300B2ï¼‰ï¼šæ•´åˆè¿‘ç´…å¤–å…‰è­œï¼ˆNIRSï¼‰èˆ‡æ·±åº¦å­¸ç¿’ï¼Œå¯¦ç¾æ–‘å¡Šæˆåˆ†çš„åƒç´ ç´šåˆ†é¡ï¼Œå¯æª¢æ¸¬è„‚è³ªæ ¸å¿ƒèˆ‡å¾®éˆ£åŒ–å€åŸŸ[6](https://patents.google.com/patent/US11488300B2/ko)
        

## æ–‘å¡Šç‰¹å¾µåˆ†ææŠ€è¡“

1. **æˆåˆ†è­˜åˆ¥**
    
    - **è™›æ“¬çµ„ç¹”å­¸å¼·åŒ–**ï¼šåŸºæ–¼å°„é »ä¿¡è™Ÿçš„VH-IVUSçµåˆç”Ÿæˆå°æŠ—ç¶²çµ¡ï¼ˆGANï¼‰ï¼Œä½¿è–„çº–ç¶­å¸½ç²¥æ¨£æ–‘å¡Šï¼ˆTCFAï¼‰è­˜åˆ¥æ•æ„Ÿåº¦å¾54%æå‡è‡³82%ï¼Œéˆ£åŒ–æ–‘å¡Šè§’åº¦æ¸¬é‡èª¤å·®å¾Â±15Â°é™è‡³Â±5Â°[8](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.00107/full)[14](https://pubs.rsna.org/doi/abs/10.1148/ryct.230312)
        
    - **å¤šæ¨¡æ…‹èåˆ**ï¼šå°ˆåˆ©CN105228518Bæè¿°IVUSèˆ‡è¡€æµå„²å‚™åˆ†æ•¸ï¼ˆFFRï¼‰çš„ç‰¹å¾µç´šèåˆï¼Œç•¶æ–‘å¡Šè² è·ï¼70%ä¸”FFRâ‰¤0.80æ™‚ï¼Œç³»çµ±è‡ªå‹•æ¨™è¨˜è¡€æµé™åˆ¶æ€§ç—…è®Šï¼Œè¨ºæ–·ä¸€è‡´æ€§æå‡28%[6](https://patents.google.com/patent/US11488300B2/ko)
        
2. **é¢¨éšªé æ¸¬æ¨¡å‹**
    
    - **XGBoostæ•´åˆ107é …ç‰¹å¾µ**ï¼šçµåˆå½±åƒçµ„å­¸èˆ‡è‡¨åºŠåƒæ•¸ï¼Œé æ¸¬æ”¯æ¶å…§å†ç‹¹çª„é¢¨éšªçš„AUCé”0.93ï¼Œé«˜é¢¨éšªç‰¹å¾µåŒ…æ‹¬æ–‘å¡Šè² è·ï¼55%ã€éˆ£åŒ–é•·åº¦ï¼5mm[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        
    - **Lipid Rich Plaque (LRP)ç ”ç©¶**ï¼šNIRS-IVUSåˆ†æé¡¯ç¤ºï¼ŒmaxLCBI4mmï¼400çš„æ‚£è€…éç½ªçŠ¯è¡€ç®¡MACEé¢¨éšªå¢åŠ 3.39å€ï¼ŒFDAå·²æ ¸å‡†å…¶ç”¨æ–¼é¢¨éšªåˆ†å±¤[8](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.00107/full)
        

## æ”¯æ¶æª¢æ¸¬èˆ‡è¡“ä¸­å°èˆª

1. **æ”¯æ¶çµæ§‹åˆ†æ**
    
    - **DeepLabV3+æ¨¡å‹**ï¼šåœ¨45,449å¼µæ”¯æ¶å½±åƒæ•¸æ“šé›†ä¸­ï¼Œæ”¯æ¶é¢ç©åˆ†å‰²çš„IoUé”0.84ï¼Œèˆ‡å°ˆå®¶æ¸¬é‡ç›¸é—œä¿‚æ•¸r=0.99ï¼Œé¡¯è‘—é™ä½æ”¯æ¶è²¼å£ä¸è‰¯æª¢æ¸¬æ™‚é–“[16](https://pubmed.ncbi.nlm.nih.gov/33741429/)[17](https://www.ahajournals.org/doi/10.1161/circ.142.suppl_3.17365)
        
    - **æ™‚åºRNNæ¶æ§‹**ï¼šåˆ†ææ”¯æ¶é‹¼æ¢éš¨å¿ƒå‹•é€±æœŸçš„å‹•æ…‹è®ŠåŒ–ï¼Œå¯æª¢æ¸¬å¾®ç±³ç´šè²¼å£ä¸è‰¯ï¼ˆï¼200Î¼mï¼‰ï¼Œä½¿è¡“å¾Œè¡€æ “é¢¨éšªé™ä½34%[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        
2. **æ‰‹è¡“å°èˆªç³»çµ±**
    
    - **SyncVisionå…±é…æº–æŠ€è¡“**ï¼šçµåˆè¡€ç®¡é€ å½±èˆ‡IVUS 3Dé‡å»ºï¼Œå¯¦æ™‚é¡¯ç¤ºæ”¯æ¶è†¨è„¹æŒ‡æ•¸ï¼ˆï¼80%åƒè€ƒç®¡è…”é¢ç©ï¼‰ï¼Œä½¿é¶è¡€ç®¡å¤±æ•—ç‡é™ä½27%[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC10173041/)
        
    - **AI-QCAæ•´åˆç³»çµ±**ï¼šè‡ªå‹•æ¸¬é‡åƒè€ƒè¡€ç®¡ç›´å¾‘èˆ‡ç—…è®Šé•·åº¦ï¼Œèˆ‡IVUSçš„ç›¸é—œä¿‚æ•¸r=0.92ï¼ˆè¿‘ç«¯åƒè€ƒé¢ç©ï¼‰åŠr=0.85ï¼ˆæ–‘å¡Šè² è·ï¼‰ï¼Œåœ°ç†éŒ¯ä½ä¿®æ­£å¾Œä¸€è‡´æ€§æå‡15%[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC10173041/)
        

## å¤šæ¨¡æ…‹èåˆæŠ€è¡“

1. **å½±åƒ-åŠŸèƒ½å­¸æ•´åˆ**
    
    - **CT-FFRèˆ‡IVUSèåˆ**ï¼šAI-QCPAç³»çµ±åˆ†æCCTAå½±åƒï¼Œæ–‘å¡Šé«”ç©èˆ‡IVUSçš„Spearmanç›¸é—œä¿‚æ•¸Ï=0.94ï¼ˆå…¨è¡€ç®¡ï¼‰åŠÏ=0.97ï¼ˆç®¡è…”ï¼‰ï¼Œéˆ£åŒ–æ–‘å¡Šæª¢æ¸¬ä¸€è‡´æ€§Îº=0.87[14](https://pubs.rsna.org/doi/abs/10.1148/ryct.230312)
        
    - **OCT-IVUSè¯åˆæ¨¡å‹**ï¼šåˆ©ç”¨åœ–ç¥ç¶“ç¶²çµ¡ï¼ˆGNNï¼‰åŒæ­¥è™•ç†å…©ç¨®å½±åƒæ•¸æ“šï¼Œä½¿éˆ£åŒ–è§’åº¦æ¸¬é‡èª¤å·®å¾Â±15Â°é™è‡³Â±5%ï¼Œæå‡è¤‡é›œç—…è®Šè©•ä¼°ç²¾åº¦[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        
2. **è·¨æ¨¡æ…‹ç”ŸæˆæŠ€è¡“**
    
    - **Super-Resolution IVUS**ï¼šåŸºæ–¼GANçš„è¶…è§£ææŠ€è¡“ï¼Œå°‡ç©ºé–“è§£æåº¦å¾100Î¼mæå‡è‡³40Î¼mï¼Œå¯è­˜åˆ¥65Î¼mä»¥ä¸‹è–„çº–ç¶­å¸½ï¼Œæ•æ„Ÿåº¦æå‡2.3å€[12](https://pmc.ncbi.nlm.nih.gov/articles/PMC11198165/)
        
    - **MONAIæ¡†æ¶**ï¼šèˆ‡NVIDIAåˆä½œé–‹ç™¼çš„å¯¦æ™‚é™å™ªæŠ€è¡“ï¼Œä½¿ä½åŠ‘é‡IVUSå½±åƒä¿¡å™ªæ¯”æå‡42%ï¼Œè¼»å°„åŠ‘é‡é™ä½23%[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        

## å°ˆåˆ©æŠ€è¡“ç™¼å±•

1. **å½±åƒåˆ†æç³»çµ±**
    
    - **US11488300B2**ï¼šæ•´åˆæ·±åº¦å­¸ç¿’èˆ‡NIRS-IVUSï¼Œå¯¦ç¾æ–‘å¡Šæˆåˆ†çš„åƒç´ ç´šåˆ†é¡ï¼ˆè„‚è³ªæ ¸å¿ƒã€çº–ç¶­çµ„ç¹”ã€éˆ£åŒ–ï¼‰ï¼Œä¸¦é‡åŒ–æ–‘å¡Šæ˜“ææ€§æŒ‡æ•¸[6](https://patents.google.com/patent/US11488300B2/ko)
        
    - **CN105228518B**ï¼šå¤šæ¨¡æ…‹ç‰¹å¾µèåˆæ¶æ§‹ï¼Œå¯åŒæ­¥è™•ç†IVUSã€FFRåŠè¡€ç®¡é€ å½±æ•¸æ“šï¼Œè‡ªå‹•ç”Ÿæˆæ²»ç™‚å»ºè­°åƒæ•¸ï¼ˆæ”¯æ¶å°ºå¯¸ã€æ“´å¼µå£“åŠ›ï¼‰[6](https://patents.google.com/patent/US11488300B2/ko)
        
2. **è¡“ä¸­å°èˆªè£ç½®**
    
    - **Pioneer Pluså°ç®¡**ï¼šå…§å»ºAIå°å¼•çš„é›™ç·šç³»çµ±ï¼Œåœ¨CTOç—…è®Šä¸­å¯¦ç¾95%-100%å†é€²å…¥æˆåŠŸç‡ï¼Œæ¸›å°‘è¡€ç®¡ç©¿å­”é¢¨éšª[8](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.00107/full)
        
    - **Reconnaissance PVå°ç®¡**ï¼šéŒå½¢å°–ç«¯è¨­è¨ˆçµåˆå¯¦æ™‚æ–‘å¡Šç¡¬åº¦åˆ†æï¼Œä½¿éˆ£åŒ–æ‰­æ›²ç—…è®Šé€šéç‡æå‡55%[8](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.00107/full)
        

## è‡¨åºŠé©—è­‰èˆ‡æŒ‘æˆ°

1. **æ•ˆèƒ½é©—è­‰æ•¸æ“š**
    
    - **å¤§è¦æ¨¡çœŸå¯¦ä¸–ç•Œç ”ç©¶**ï¼šAIè¼”åŠ©IVUSä½¿æ”¯æ¶è†¨è„¹ä¸å…¨ç™¼ç”Ÿç‡å¾22%é™è‡³7%ï¼Œé‚Šæ”¯é–‰å¡é¢¨éšªé™ä½41%ï¼Œ2å¹´æ²»ç™‚æˆæœ¬å¹³è¡¡[12](https://pmc.ncbi.nlm.nih.gov/articles/PMC11198165/)[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        
    - **FDA De Novoèªè­‰**ï¼šåœ¨35å€‹ä¸­å¿ƒé©—è­‰ï¼Œæ–‘å¡Šè² è·æ¸¬é‡èˆ‡OCTçš„ICC=0.93ï¼Œæ”¯æ¶è²¼å£åˆ¤æ–·Cohen's Kappa=0.88[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        
2. **æŠ€è¡“ç“¶é ¸**
    
    - **ç•°æ§‹æ•¸æ“šæ•´åˆ**ï¼šç¾æœ‰æ¨¡å‹å°æ”¯æ¶èˆ‡éˆ£åŒ–é™°å½±å€åŸŸçš„åˆ†å‰²IoUåƒ…0.64-0.66ï¼Œéœ€ç™¼å±•GNNæ¶æ§‹æ”¹å–„å¤šæ¨¡æ…‹èåˆ[1](https://pubmed.ncbi.nlm.nih.gov/34351974/)[9](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0255577)
        
    - **ç®—æ³•å¯è§£é‡‹æ€§**ï¼šè‡¨åºŠæ‡‰ç”¨éœ€ç¬¦åˆISO 13485èˆ‡IEC 62304æ¨™æº–ï¼Œç¾è¡Œé»‘ç®±æ¨¡å‹é›£ä»¥æ»¿è¶³é†«ç™‚å™¨æ¢°å¯©æ ¸è¦æ±‚[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC10784612/)[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
        

## æœªä¾†ç™¼å±•æ–¹å‘

1. **é‡å­è¨ˆç®—åŠ é€Ÿ**ï¼šæ‡‰ç”¨æ–¼è¡€ç®¡å£æ‡‰åŠ›åˆ†å¸ƒçš„æ¯«ç§’ç´šè¨ˆç®—ï¼Œé è¨ˆ2026å¹´é€²å…¥è‡¨åºŠè©¦é©—éšæ®µ[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
    
2. **å…¨æ¯å°èˆªç³»çµ±**ï¼šçµåˆ5Gå‚³è¼¸èˆ‡ARæŠ€è¡“ï¼Œå¯¦ç¾è£¸çœ¼3Dæ‰‹è¡“å°èˆªï¼Œæå‡è¤‡é›œç—…è®Šè™•ç†ç²¾åº¦[8](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.00107/full)
    
3. **é é˜²é†«å­¸æ‡‰ç”¨**ï¼šé–‹ç™¼åŸºæ–¼å½±åƒçµ„å­¸çš„å‹•è„ˆç²¥æ¨£ç¡¬åŒ–é€²å±•æ¨¡å‹ï¼Œç›®æ¨™5å¹´å¿ƒè¡€ç®¡äº‹ä»¶é æ¸¬AUCï¼0.90[13](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100565)
    

ï¼ˆæ³¨ï¼šä»¥ä¸Šå†…å®¹å‡åŸºæ–¼æä¾›çš„æ–‡ç»è³‡æ–™æ•´ç†ï¼Œå¼•ç”¨ä¾†æºæ¨™è¨»æ–¼æ–¹æ‹¬è™Ÿå…§ï¼‰


### è¡€ç®¡å…§è¶…éŸ³æ³¢ (IVUS) å½±åƒå† ç‹€å‹•è„ˆé‚Šç•Œåˆ†å‰²æ¼”ç®—æ³•çš„æœ€æ–°é€²å±•ç¶œè¿°


|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| -------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| IVUS goal                                          | 3D reconstruction of arteries(å‹•è„ˆ), estimation of plaque composition(æ–‘å¡Šæˆåˆ†), measuring vessel parameters(è¡€ç®¡åƒæ•¸) and optimizing stent implantation(æ”¯æ¶æ¤å…¥).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVUS segmentation                                  | direct border detection(ç›´æ¥é‚Šç•Œæª¢æ¸¬), blood speckle noise reduction(è¡€æ¶²æ–‘é»å™ªéŸ³é™ä½), and luminal and blood pool areas analysis(ç®¡è…”å’Œè¡€æ± å€åŸŸåˆ†æ), U-Net. <br><br>lot of room for images corrupted with artifacts(å½å½±) and calcification(éˆ£åŒ–ç ´å£) to be investigated.<br><br>special attention towards complex calcified lesions(è¤‡é›œçš„éˆ£åŒ–ç—…è®Š), and speckle noise suppression(æ–‘é»å™ªè²æŠ‘åˆ¶) algorithms to be employed for arterial border detection(å‹•è„ˆé‚Šç•Œæª¢æ¸¬). pre-processing method or not in detecting the lumen(ç®¡è…”) and MA borders                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| coronary heart disease (CAD)å† å¿ƒç—…                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| vulnerable plaques (VP)æ˜“ææ–‘å¡Š                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVUS (Intravascular Ultrasoundï¼Œè¡€ç®¡å…§è¶…éŸ³æ³¢)             | ä¸€ç¨®ä½¿ç”¨å°å‹è¶…éŸ³æ³¢æ¢é ­åœ¨è¡€ç®¡å…§é€²è¡Œæˆåƒçš„æŠ€è¡“ï¼Œç”¨æ–¼è©•ä¼°è¡€ç®¡å£çµæ§‹å’Œæ–‘å¡Šç‰¹æ€§ã€‚IVUS æˆåƒæä¾›å®Œæ•´çš„å† ç‹€å‹•è„ˆ 360 åº¦å¯è¦–åŒ–ï¼Œå…·å‚™é«˜è§£æåº¦ï¼Œä¸”èƒ½æä¾›è¡€ç®¡å£é‡å¡‘ã€è¡€ç®¡å£å¹¾ä½•å½¢ç‹€ã€æ–‘å¡Šåˆ†ä½ˆã€å‹•è„ˆç²¥ç‹€ç¡¬åŒ–ç—…ç¶çš„æ€§è³ªç­‰ä¿¡æ¯ã€‚å‚³çµ±è¡€ç®¡æ”å½±è¡“çš„å±€é™æ€§åŒ…æ‹¬é›£ä»¥å€åˆ†æœ‰æˆ–ç„¡æ­£å‘é‡å¡‘çš„è¡€ç®¡ï¼Œåƒ…é¡¯ç¤º 2 ç¶­ luminogramï¼Œä¸æä¾›å† ç‹€å‹•è„ˆæ–‘å¡Šç‰¹æ€§ç­‰ã€‚<br><br>æä¾›å† ç‹€å‹•è„ˆçš„å®šæ€§ä¼°è¨ˆï¼ŒåŒ…æ‹¬ä¸­è†œå¤–è†œ (MA) é‚Šç•Œã€ç®¡è…”é¢ç©ã€æ–‘å¡Šåˆ†ä½ˆã€å‹•è„ˆç²¥ç‹€ç¡¬åŒ–ç—…è®Šæ€§è³ªã€è¡€ç®¡å£é‡å¡‘å’Œå½¢ç‹€çš„è³‡è¨Šã€‚media-adventitia (MA) border, lumen area, plaque distribution, atherosclerotic lesions nature, remodelling of the vessel wall, and shape. å‹•è„ˆçš„æ©«æ–·é¢åœ–é‚„æä¾›æœ‰é—œå„ç¨®ç‰¹å¾µçš„ä¿¡æ¯ï¼Œä¾‹å¦‚å† ç‹€å‹•è„ˆå±¤ï¼ˆå…§è†œã€ä¸­è†œå’Œå¤–è†œï¼‰ã€ç®¡è…”é¢ç©ã€è¡€ç®¡å£å¹¾ä½•å½¢ç‹€ã€è©•ä¼°è§£å‰–ã€åˆ†å‰ç­‰ç­‰ã€‚ IVUS åœ¨ PCI æœŸé–“ç¶“å¸¸ç”¨æ–¼å°ç®¡å®¤ï¼Œå› ç‚ºå®ƒæœ‰åŠ©æ–¼é€éç¢ºå®šå‹•è„ˆç²¥ç‹€ç¡¬åŒ–æ–‘å¡Šæˆ–å‹•è„ˆç²¥æ¨£ç¡¬åŒ–çš„é«”ç©ä¾†æº–ç¢ºè©•ä¼°æ”¯æ¶å…§å†ç‹¹çª„ã€æ”¯æ¶ç½®å…¥å’Œæ”¯æ¶æ“´å¼µæƒ…æ³<br><br>IVUS æˆåƒç³»çµ±ä¸­æœ€é‡è¦çš„å…©å€‹çµ„æˆéƒ¨åˆ†æ˜¯ IVUS æˆåƒç³»çµ±å’Œ IVUS å°ç®¡ã€‚æˆåƒç³»çµ±ç”¢ç”Ÿè¶…éŸ³æ³¢è¨Šè™Ÿä»¥é¡¯ç¤ºå½±åƒï¼Œè€Œè½‰æ›å™¨ä»¥æŒ‡å®šçš„é »ç‡é‹ä½œä»¥æ•ç²ç”¢ç”Ÿçš„è¨Šè™Ÿã€‚1. IVUS å°ç®¡çš„é »ç‡ç¯„åœåœ¨ 20 MHz åˆ° 60 MHz ä¹‹é–“, é€Ÿç‡è¨­å®šåœ¨30åˆ°60å¹€/ç§’ä¹‹é–“ã€‚åœ¨ä¸åŒçš„è½‰æ›å™¨é »ç‡ä¸‹æ‹æ”çš„å½±åƒæœƒé¡¯ç¤ºä¸åŒçš„æ•£æ–‘æ¨¡å¼ã€ç›¸å¹²å’Œéç›¸å¹²çµæ§‹ã€ç©¿é€åŠ›å’Œè»¸å‘è§£æåº¦ã€‚å…¸å‹çš„ IVUS åºåˆ—åœ¨å›æ‹‰éç¨‹ä¸­æœƒç”¢ç”Ÿå¤§ç´„æ•¸åƒå¹€çš„é«”ç©æ•¸æ“š, ç”¢ç”Ÿçš„ IVUS å½±åƒå°æ¯”åº¦ç‰¹åˆ¥ä½ä¸”æœ‰å½å½±ã€‚<br><br>åœ¨ IVUS å½±åƒåˆ†å‰²æ¼”ç®—æ³•ä¸­ï¼Œå“ªä¸€é¡æ–¹æ³•å¯ç›´æ¥è©•ä¼°å‹•è„ˆé‚Šç•Œå’Œæ–‘å¡Šä½ç½®ï¼Œé€²è€Œæº–ç¢ºæ¤å…¥æ”¯æ¶æˆ–é€²è¡Œæ°£çƒæ“´å¼µè¡“ï¼Ÿç›´æ¥æª¢æ¸¬é‚Šç•Œæ˜¯ IVUS å½±åƒåˆ†å‰²çš„ä¸€é¡æ–¹æ³•ï¼Œå®ƒå¯ä»¥ç›´æ¥è©•ä¼°å‹•è„ˆé‚Šç•Œå’Œæ–‘å¡Šä½ç½®ï¼Œé€™å°æ–¼çµ„ç¹”è¡¨å¾µéå¸¸é‡è¦ã€‚é€™äº›æ¸¬é‡æœ‰åŠ©æ–¼æº–ç¢ºæ¤å…¥æ”¯æ¶æˆ–åœ¨æ°£çƒè¡€ç®¡æˆå½¢è¡“æœŸé–“ã€‚<br><br>ç›®å‰ IVUS å½±åƒåˆ†æé ˜åŸŸé¢è‡¨çš„æŒ‘æˆ°åŒ…æ‹¬å­˜åœ¨ç•°å¸¸çµæ§‹ï¼Œå¦‚çº–ç¶­åŒ–æ–‘å¡Šã€éˆ£åŒ–ç­‰ï¼Œå…§åœ¨å½å½±ï¼ˆå¦‚é™°å½±ã€åˆ†å‰ç­‰ï¼‰ï¼Œä»¥åŠä¸€äº›æ–‘é»å™ªè²ï¼Œé€™äº›ä½¿æ¸…æ™°çš„æª¢æ¸¬æˆç‚ºä¸€é …å…·æœ‰æŒ‘æˆ°æ€§çš„ä»»å‹™abnormal structures such as fibrotic plaques, calcifications, etc., intrinsic artifacts (e.g. shadows, bifurcations, etc.), and some speckle noises which make the clear detection a challenging task. å¾ IVUS å½±åƒä¸­åˆ†å‰²å‹•è„ˆå£é‚Šç•Œé™¤äº†å°æ–¼å®šé‡ç ”ç©¶è¡€ç®¡å£å’Œæ–‘å¡Šç‰¹å¾µè‡³é—œé‡è¦ä¹‹å¤–ï¼Œå°æ–¼å»ºç«‹å‹•è„ˆçš„ 3D é‡å»ºæ¨¡å‹ã€å„ªåŒ–æ”¯æ¶æ¤å…¥ç­‰ä¹Ÿæ˜¯å¿…è¦çš„ |
| percutaneous coronary intervention (PCI)ç¶“çš®å† ç‹€å‹•è„ˆä»‹å…¥æ²»ç™‚ |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVUS Artifacts  IVUS å½å½±                            | ï¼ˆaï¼‰å› å¯†é›†çš„éˆ£è³ªæ²‰ç©è€Œå¼•èµ·çš„è²å½±  <br>Acoustic Shadows Artifact Calciumï¼Œï¼ˆbï¼‰æŒ¯éˆ´å½å½±Ring-down Artifactï¼Œï¼ˆcï¼‰æ··éŸ¿å½å½±Reverberation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Algorithm outline                                  | 1. ç›´æ¥æª¢æ¸¬é‚Šç•Œ<br>	é‚Šç·£è·Ÿè¸ªå’ŒåŸºæ–¼æ¢¯åº¦<br>	åŸºæ–¼æ´»å‹•è¼ªå»“<br>	åŸºæ–¼çµ±è¨ˆå’Œæ©Ÿç‡<br>	åŸºæ–¼å¤šå°ºåº¦æ“´å±•<br>	åŸºæ–¼æ©Ÿå™¨å­¸ç¿’<br>2. è¡€æ¶²æ–‘é»é™å™ª<br><br>3. ç®¡è…”åŠè¡€æ± é¢ç©åˆ†æåŠç‰¹å¾µæå–                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

é€™æ®µ **è·ä½æè¿°** ä¸»è¦å¼·èª¿ **æ©Ÿå™¨å­¸ç¿’é–‹ç™¼èˆ‡éƒ¨ç½²** éœ€è¦ç¬¦åˆç›¸é—œ**é†«ç™‚å™¨ææ³•è¦èˆ‡æ¨™æº–**ï¼Œä¸¦ä¸”åƒèˆ‡é¢¨éšªè©•ä¼°ä»¥ç¢ºä¿**é†«ç™‚AIçš„å®‰å…¨æ€§èˆ‡åˆè¦æ€§**ã€‚ä»¥ä¸‹æ˜¯è©³ç´°è§£æï¼š

---

## **1. ç¬¦åˆæ³•è¦æ¨™æº–**

æ©Ÿå™¨å­¸ç¿’æŠ€è¡“åœ¨**é†«ç™‚é ˜åŸŸï¼ˆå¦‚å½±åƒè¨ºæ–·ã€ç—…ç†åˆ†æã€è‡¨åºŠæ±ºç­–æ”¯æŒï¼‰**çš„æ‡‰ç”¨ï¼Œå—åˆ°åš´æ ¼çš„æ³•è¦ç›£ç®¡ã€‚è©²è·è²¬è¦æ±‚**ç¢ºä¿æ‰€æœ‰æ©Ÿå™¨å­¸ç¿’é–‹ç™¼èˆ‡éƒ¨ç½²ç¬¦åˆä»¥ä¸‹æ¨™æº–**ï¼š

### **(1) FDA (Food and Drug Administration)**

- **ç¾åœ‹é£Ÿå“è—¥å“ç›£ç£ç®¡ç†å±€ï¼ˆFDAï¼‰** å°**é†«ç™‚å™¨æä¸­çš„æ©Ÿå™¨å­¸ç¿’**ï¼ˆAI/ML in Medical Devicesï¼‰æœ‰åš´æ ¼çš„ç›£ç®¡ã€‚
- ç›¸é—œçš„**è»Ÿé«”å³é†«ç™‚å™¨æï¼ˆSaMD, Software as a Medical Deviceï¼‰** éœ€è¦éµå®ˆï¼š
    - **510(k) èªè­‰**ï¼šå°æ¯”å·²æ‰¹å‡†çš„é¡ä¼¼ç”¢å“ä»¥ç²å¾—å¸‚å ´è¨±å¯
    - **PMA (Pre-Market Approval)**ï¼šç”¨æ–¼é«˜é¢¨éšªé†«ç™‚å™¨æ¢°çš„åš´æ ¼å¯©æŸ¥
    - **De Novo Classification**ï¼šå°æ–¼å‰µæ–°ä½†ä½é¢¨éšªçš„é†«ç™‚AIé€²è¡Œè©•ä¼°

ğŸ’¡ **æ©Ÿå™¨å­¸ç¿’æ¨¡å‹éœ€ç¬¦åˆ**ï¼š

- **é€æ˜æ€§**ï¼šç¢ºä¿AIæ±ºç­–å¯è§£é‡‹ï¼Œç¬¦åˆ **FDA "Good Machine Learning Practice"ï¼ˆGMLPï¼‰**
- **æ•¸æ“šä¾†æºèˆ‡æ¨™æº–åŒ–**ï¼šç¢ºä¿æ•¸æ“šä¾†æºåˆæ³•ï¼Œä¸¦ç¬¦åˆ **FDA Data Integrity Guidance**
- **æ€§èƒ½è©•ä¼°èˆ‡ç›£ç®¡**ï¼šæä¾› **æ¨¡å‹æ¸¬è©¦ã€é©—è­‰ã€å¯è®Šæ›´æ€§è¨ˆåŠƒï¼ˆML-Change Controlï¼‰**

---

### **(2) MDR (Medical Device Regulation, æ­ç›Ÿé†«ç™‚å™¨æ¢°æ³•è¦)**

- MDR æ–¼ **2021 å¹´æ­£å¼å–ä»£èˆŠç‰ˆ MDDï¼ˆMedical Device Directiveï¼‰**ï¼Œå°é†«ç™‚AIæœ‰æ›´åš´æ ¼è¦ç¯„ã€‚
- **å½±éŸ¿AIçš„é‡é»**ï¼š
    - AI **é–‹ç™¼éç¨‹çš„æŠ€è¡“æ–‡æª”è¦æ±‚**
    - AI **é€æ˜æ€§ã€è§£é‡‹æ€§èˆ‡å¯è¿½æº¯æ€§**
    - **æŒçºŒç›£æ¸¬ï¼ˆPost-market Surveillance, PMSï¼‰** ç¢ºä¿éƒ¨ç½²å¾Œä»ç¬¦åˆè¦ç¯„

---

### **(3) ISO 13485ï¼ˆé†«ç™‚å™¨æ¢°å“è³ªç®¡ç†ç³»çµ±ï¼‰**

- é©ç”¨æ–¼é–‹ç™¼ã€è£½é€ ã€ç¶­è­·é†«ç™‚å™¨æçš„å“è³ªç®¡ç†æ¨™æº–ï¼Œæ¶µè“‹ï¼š
    - **æ©Ÿå™¨å­¸ç¿’è»Ÿé«”é–‹ç™¼æµç¨‹**
    - **æ•¸æ“šç®¡ç†èˆ‡æ¨™æº–åŒ–**
    - **é¢¨éšªç®¡ç†è¦æ±‚**
    - **å¯è¿½æº¯æ€§èˆ‡å¯©è¨ˆè¨˜éŒ„**

ğŸ’¡ **ç¢ºä¿MLé–‹ç™¼ç¬¦åˆ ISO 13485 å¯æé«˜ FDA/MDR èªè­‰æˆåŠŸç‡**

---

### **(4) IEC 62304ï¼ˆé†«ç™‚è»Ÿé«”é–‹ç™¼ç”Ÿå‘½é€±æœŸæ¨™æº–ï¼‰**

- å°ˆé–€é‡å° **é†«ç™‚è¨­å‚™è»Ÿé«”** çš„é–‹ç™¼æ¨™æº–ï¼Œé©ç”¨æ–¼ AI é†«ç™‚æ‡‰ç”¨
- **é‡é»è¦æ±‚**ï¼š
    - **è»Ÿé«”åˆ†é¡**ï¼šå€åˆ†å®‰å…¨é¢¨éšªï¼ˆA/B/C ç´šï¼ŒC ç´šé¢¨éšªæœ€é«˜ï¼‰
    - **è»Ÿé«”é–‹ç™¼æµç¨‹**ï¼šéœ€æ±‚è¦ç¯„ã€è¨­è¨ˆã€é©—è­‰ã€ç¶­è­·
    - **é¢¨éšªç®¡ç†**ï¼šè¦æ±‚ç¬¦åˆ **ISO 14971**

ğŸ’¡ **é€™ä»£è¡¨é–‹ç™¼ ML æ¨¡å‹æ™‚ï¼Œéœ€æœ‰åš´æ ¼çš„ç‰ˆæœ¬ç®¡ç†ã€æ¸¬è©¦èˆ‡é©—è­‰æµç¨‹ï¼Œé¿å…ã€Œé»‘ç®± AIã€ç„¡æ³•é€šéé†«ç™‚å¯©æŸ¥ã€‚**

---

### **(5) ISO 14971ï¼ˆé†«ç™‚å™¨æé¢¨éšªç®¡ç†æ¨™æº–ï¼‰**

- **æ ¸å¿ƒæ¦‚å¿µ**ï¼šAI ç”¢å“éœ€é€²è¡Œ**å…¨é¢é¢¨éšªè©•ä¼°**ï¼Œæ¶µè“‹ï¼š
    - **æ¨¡å‹æº–ç¢ºåº¦èˆ‡ä¸ç¢ºå®šæ€§**ï¼ˆFalse Positive/False Negative é¢¨éšªï¼‰
    - **æ•¸æ“šåå·®èˆ‡å…¬å¹³æ€§**ï¼ˆé¿å… AI å½±éŸ¿ä¸åŒæ—ç¾¤çš„è¨ºæ–·çµæœï¼‰
    - **å°æ‚£è€…çš„æ½›åœ¨å½±éŸ¿**ï¼ˆå¦‚ AI è¨ºæ–·éŒ¯èª¤æ˜¯å¦å¯èƒ½å°è‡´å»¶é²æ²»ç™‚ï¼Ÿï¼‰

ğŸ’¡ **é–‹ç™¼é†«ç™‚AIæ™‚ï¼Œéœ€è€ƒæ…®é¢¨éšªä¸¦æä¾›é¢¨éšªæ§åˆ¶æªæ–½ï¼Œå¦‚æ¨¡å‹ç›£æ§ã€è­¦ç¤ºæ©Ÿåˆ¶ç­‰ã€‚**

---

## **2. åƒèˆ‡é¢¨éšªè©•ä¼°ä¸¦æ¸›è¼•æ©Ÿå™¨å­¸ç¿’æ¨¡å‹é¢¨éšª**

é¢¨éšªè©•ä¼°ï¼ˆRisk Assessmentï¼‰æ˜¯ç¢ºä¿ AI æ¨¡å‹ç¬¦åˆ**é†«ç™‚æ³•è¦çš„æ ¸å¿ƒæ­¥é©Ÿ**ï¼Œéœ€è­˜åˆ¥èˆ‡é™ä½ **å¯èƒ½å½±éŸ¿å®‰å…¨èˆ‡æ•ˆèƒ½çš„é¢¨éšª**ã€‚

### **(1) é¢¨éšªè­˜åˆ¥ï¼ˆRisk Identificationï¼‰**

- **æ¨¡å‹è¼¸å…¥é¢¨éšª**ï¼š
    
    - **å½±åƒå“è³ªè®Šç•°æ€§**ï¼ˆä¸åŒè¨­å‚™æˆ–æƒææ¢ä»¶å½±éŸ¿è¨ºæ–·çµæœï¼‰
    - **æ•¸æ“šç•°å¸¸**ï¼ˆå¦‚å™ªè²ã€å½å½±å½±éŸ¿ AI è¨ºæ–·ï¼‰
    - **æ‚£è€…äººç¨®/æ€§åˆ¥åå·®**ï¼ˆå¯èƒ½å½±éŸ¿ AI æ¨¡å‹å…¬å¹³æ€§ï¼‰
- **æ¨¡å‹è¡Œç‚ºé¢¨éšª**ï¼š
    
    - **False Positive/False Negative**ï¼ˆéŒ¯èª¤è¨ºæ–·å½±éŸ¿é†«ç™‚æ±ºç­–ï¼‰
    - **æ¨¡å‹éåº¦æ“¬åˆï¼ˆOverfittingï¼‰** å°è‡´æ–°æ•¸æ“šè¡¨ç¾ä¸ä½³
    - **è§£é‡‹æ€§ä¸è¶³ï¼ˆLack of Explainabilityï¼‰** é™ä½é†«ç”Ÿä¿¡ä»»åº¦
- **ç³»çµ±é¢¨éšª**ï¼š
    
    - **æ•¸æ“šå®‰å…¨èˆ‡éš±ç§**ï¼ˆéµå¾ª HIPAAã€GDPRï¼Œç¢ºä¿æ‚£è€…è³‡æ–™ä¸æ´©éœ²ï¼‰
    - **é†«ç™‚AIæ¨¡å‹å‡ç´šå½±éŸ¿**ï¼ˆéœ€æä¾› **è®Šæ›´ç®¡ç†è¨ˆåŠƒ**ï¼‰

---

### **(2) é¢¨éšªæ¸›è¼•ï¼ˆRisk Mitigationï¼‰**

é‡å°ä¸Šè¿°é¢¨éšªï¼Œå¯é€é **æŠ€è¡“ã€æ³•è¦ã€æµç¨‹** é€²è¡Œç·©è§£ï¼š

#### **æŠ€è¡“æ–¹æ³•**

- **è³‡æ–™å¢å¼·ï¼ˆData Augmentationï¼‰**ï¼šå¢åŠ è¨“ç·´æ•¸æ“šçš„å¤šæ¨£æ€§ï¼Œæ¸›å°‘åå·®
- **å…¬å¹³æ€§æ¸¬è©¦ï¼ˆFairness Testingï¼‰**ï¼šè©•ä¼° AI åœ¨ä¸åŒæ—ç¾¤çš„è¨ºæ–·æº–ç¢ºåº¦
- **å¯è§£é‡‹æ€§ï¼ˆExplainable AI, XAIï¼‰**ï¼šæä¾›å¯è¦–åŒ–çš„ AI è¨ºæ–·çµæœï¼Œå¢å¼·é€æ˜åº¦

#### **æ³•è¦åˆè¦**

- **é†«ç™‚æ•¸æ“šåŒ¿ååŒ–ï¼ˆDe-identificationï¼‰**ï¼šç¬¦åˆ GDPR/HIPAA
- **æŒçºŒç›£æ¸¬ï¼ˆPost-Market Monitoringï¼‰**ï¼šç¢ºä¿ AI åœ¨å¯¦éš›æ‡‰ç”¨ä¸­æŒçºŒæœ‰æ•ˆ
- **ç‰ˆæœ¬æ§åˆ¶èˆ‡è®Šæ›´ç®¡ç†ï¼ˆChange Managementï¼‰**ï¼šç¢ºä¿æ¯æ¬¡æ¨¡å‹å‡ç´šéƒ½æœ‰å®Œæ•´æ–‡æª”è¨˜éŒ„

---

## **3. è©²è·ä½çš„æ ¸å¿ƒæŠ€èƒ½**

ğŸ’¡ **å…·å‚™é€™äº›æŠ€èƒ½å°‡æœ‰åŠ©æ–¼å‹ä»»æ­¤è·ä½**ï¼š âœ… **æ©Ÿå™¨å­¸ç¿’é–‹ç™¼ï¼ˆML Developmentï¼‰**ï¼šç†Ÿæ‚‰ PyTorchã€TensorFlowã€ONNX  
âœ… **é†«ç™‚AIæ³•è¦ï¼ˆRegulatory Complianceï¼‰**ï¼šç†Ÿæ‚‰ **FDAã€MDRã€ISO 13485ã€ISO 14971**  
âœ… **é¢¨éšªç®¡ç†ï¼ˆRisk Assessmentï¼‰**ï¼šæœ‰ **FMEAï¼ˆFailure Mode and Effects Analysisï¼‰** ç¶“é©—  
âœ… **é†«ç™‚å½±åƒè™•ç†**ï¼šäº†è§£ **DICOMã€NIfTIã€HL7 FHIR** ç­‰é†«å­¸æ•¸æ“šæ ¼å¼  
âœ… **è»Ÿé«”ç”Ÿå‘½é€±æœŸç®¡ç†ï¼ˆSDLCï¼‰**ï¼šéµå¾ª **IEC 62304**ï¼Œæœ‰ DevOps ç¶“é©—  
âœ… **å¯è§£é‡‹AIï¼ˆXAIï¼‰**ï¼šä½¿ç”¨ SHAPã€LIMEã€Grad-CAM æé«˜é€æ˜åº¦

---

# **1. AI é–‹ç™¼æµç¨‹å¦‚ä½•ç¬¦åˆé†«ç™‚æ³•è¦ï¼Ÿ**

é–‹ç™¼ **IVUS ç”¢å“çš„ AI æ¨¡å‹** éœ€è¦åš´æ ¼éµå®ˆ **é†«ç™‚å™¨ææ³•è¦èˆ‡é¢¨éšªç®¡ç†æ¨™æº–**ï¼Œé€™åŒ…æ‹¬ï¼š

|**é–‹ç™¼éšæ®µ**|**å°æ‡‰æ³•è¦**|**éœ€è¦åšçš„åˆè¦æªæ–½**|
|---|---|---|
|**æ•¸æ“šæ”¶é›†**|FDAã€MDRã€ISO 13485|**ç¢ºä¿æ•¸æ“šåˆæ³•ä¾†æº**ã€ç¬¦åˆ**GDPR/HIPAA**ã€å½±åƒæ ¼å¼ç¬¦åˆ **DICOM**ã€æ•¸æ“šæ¨™è¨»ä¸€è‡´æ€§|
|**æ¨¡å‹é–‹ç™¼**|FDA GMLPã€IEC 62304|å»ºç«‹ **å¯é‡ç¾çš„é–‹ç™¼æµç¨‹**ã€ç¢ºä¿ AI å¯è§£é‡‹æ€§ï¼ˆXAIï¼‰|
|**é¢¨éšªç®¡ç†**|ISO 14971ã€FDA QMS|é€²è¡Œ **é¢¨éšªè©•ä¼°ï¼ˆFMEA, Fault Tree Analysisï¼‰**ã€é™ä½ AI åèª¤|
|**æ¨¡å‹é©—è­‰**|FDA 510(k)ã€MDR|ä½¿ç”¨ **IVUS å½±åƒè‡¨åºŠæ•¸æ“šé€²è¡Œé©—è­‰**ï¼Œç¢ºä¿ **éˆæ•åº¦ã€ç‰¹ç•°åº¦ã€æº–ç¢ºç‡** ç¬¦åˆæ¨™æº–|
|**è»Ÿé«”æ¸¬è©¦**|IEC 62304ã€ISO 13485|å»ºç«‹ **å–®å…ƒæ¸¬è©¦ã€å›æ­¸æ¸¬è©¦**ï¼Œç¢ºä¿è»Ÿé«”ç‰ˆæœ¬å¯è¿½è¹¤|
|**è‡¨åºŠè©¦é©—**|FDA PMAã€MDR|**å¤šä¸­å¿ƒè‡¨åºŠè©¦é©—**ï¼Œç¢ºä¿ AI **é©æ‡‰æ‰€æœ‰æ—ç¾¤**|
|**ç”¢å“ç›£æ¸¬**|ISO 14971|å»ºç«‹ **Post-Market Surveillance (PMS)** æ©Ÿåˆ¶ï¼Œç›£æ¸¬ AI åœ¨è‡¨åºŠä¸Šçš„é‹è¡Œç‹€æ³|

---

# **2. AI æ¨¡å‹å¦‚ä½•ç¬¦åˆé†«ç™‚å™¨æåˆè¦è¦æ±‚ï¼Ÿ**

## **(1) ç¬¦åˆ FDAã€MDRï¼ˆé†«ç™‚å™¨æç›£ç®¡ï¼‰**

ğŸ”¹ **AI æ˜¯å¦å±¬æ–¼ "Software as a Medical Device (SaMD)"ï¼Ÿ**

- è‹¥ **AI æ¨¡å‹åƒèˆ‡è¨ºæ–·æˆ–æ²»ç™‚æ±ºç­–**ï¼Œå‰‡è¢«è¦–ç‚º **SaMD**ï¼Œéœ€éµå®ˆ FDA & MDRã€‚
- **IVUS AI æ¨¡å‹ç”¨é€”**ï¼š
    - **è¨ºæ–·å† ç‹€å‹•è„ˆç–¾ç—…ï¼ŸğŸ‘‰ éœ€è¦ 510(k) èªè­‰**
    - **è¼”åŠ©æ”¯æ¶æ¤å…¥æŒ‡å°ï¼ŸğŸ‘‰ éœ€è¦ FDA Pre-Market Approval (PMA)**

ğŸ”¹ **IVUS AI éœ€è¦ç¬¦åˆå“ªäº›æ³•è¦ï¼Ÿ**

- **FDA 510(k)**
    - è‹¥ IVUS AI æ˜¯åŸºæ–¼**ç¾æœ‰æ ¸å‡†è¨­å‚™ï¼ˆå¦‚ Philips Volcano IVUSï¼‰**ï¼Œå‰‡å¯æäº¤ **510(k)**
    - éœ€è¦èˆ‡å·²æ‰¹å‡†ç”¢å“åš**æ¯”è¼ƒæ€§æ¸¬è©¦**
- **FDA PMAï¼ˆPre-Market Approvalï¼‰**
    - è‹¥ IVUS AI æ˜¯å…¨æ–°æŠ€è¡“ï¼Œéœ€é€²è¡Œ **è‡¨åºŠè©¦é©—**
    - **éœ€è¦æ•¸ç™¾ä¾‹è‡¨åºŠæ•¸æ“š**ï¼Œè©•ä¼° **AI è¨ºæ–·æº–ç¢ºç‡ã€False Positive/False Negative**

ğŸ’¡ **å»ºè­°**ï¼š

- ä½¿ç”¨ **Philips å…§éƒ¨å·²æœ‰ IVUS ç¡¬é«”**ï¼Œæ¸›å°‘**ç¨ç«‹è¨»å†Š AI SaMD çš„é¢¨éšª**
- ç¢ºä¿ **AI è¨ºæ–·çµæœå¯è§£é‡‹**ï¼Œé™ä½é»‘ç®±é¢¨éšª

---

## **(2) ç¬¦åˆ ISO 13485ï¼ˆé†«ç™‚å™¨æå“è³ªç®¡ç†ï¼‰**

ğŸ”¹ **å¦‚ä½•è®“ AI ç¬¦åˆ ISO 13485ï¼Ÿ**

- **æ•¸æ“šç®¡ç†**ï¼š
    - å»ºç«‹ **IVUS å½±åƒæ•¸æ“šåº«**
    - **æ¨™æº–åŒ–æ•¸æ“šæ”¶é›†æµç¨‹**ï¼Œç¢ºä¿ä¸åŒè¨­å‚™æ‹æ”çš„ IVUS å½±åƒä¸€è‡´æ€§
- **é–‹ç™¼ç´€éŒ„**ï¼š
    - æ¯å€‹ **AI ç‰ˆæœ¬ï¼ˆv1.0, v1.1, v2.0ï¼‰** éœ€å®Œæ•´æ–‡æª”
    - è¨˜éŒ„ **æ¯æ¬¡åƒæ•¸èª¿æ•´**ï¼Œç¢ºä¿çµæœå¯é‡ç¾
- **æŒçºŒç›£æ¸¬ï¼ˆPost-Market Surveillance, PMSï¼‰**
    - AI è‹¥åœ¨**æ–°æ•¸æ“šä¸Šè¡¨ç¾è®Šå·®ï¼Œéœ€å›å ±ä¸¦èª¿æ•´æ¨¡å‹**

ğŸ’¡ **å»ºè­°**ï¼š

- å»ºç«‹ **ML Model Versioningï¼ˆæ©Ÿå™¨å­¸ç¿’ç‰ˆæœ¬æ§åˆ¶ï¼‰**
- ä½¿ç”¨ **MLOps Pipelineï¼ˆæ©Ÿå™¨å­¸ç¿’é‹ç¶­ï¼‰**ï¼Œè‡ªå‹•è¿½è¹¤ AI ç‰ˆæœ¬æ›´æ–°

---

## **(3) ç¬¦åˆ IEC 62304ï¼ˆé†«ç™‚è»Ÿé«”é–‹ç™¼æ¨™æº–ï¼‰**

ğŸ”¹ **IVUS AI å±¬æ–¼ IEC 62304 å“ªä¸€é¡ï¼Ÿ**

- **å®‰å…¨ç­‰ç´š A**ï¼šä¸å½±éŸ¿ç—…äººå¥åº·ï¼ˆä¸éœ€é†«ç™‚ç›£ç®¡ï¼‰
- **å®‰å…¨ç­‰ç´š B**ï¼šéŒ¯èª¤å¯èƒ½å°è‡´è¼•å¾®å‚·å®³ï¼ˆéœ€è¦è¨˜éŒ„éŒ¯èª¤ï¼‰
- **å®‰å…¨ç­‰ç´š C**ï¼šéŒ¯èª¤å¯èƒ½å°è‡´åš´é‡å‚·å®³ï¼ˆéœ€è¦å®Œæ•´é¢¨éšªç®¡ç†ï¼‰

ğŸ’¡ **IVUS AI å¯èƒ½å±¬æ–¼ B æˆ– C ç´š**ï¼Œéœ€ï¼š

1. **Unit Testingï¼ˆå–®å…ƒæ¸¬è©¦ï¼‰**ï¼šç¢ºä¿ AI é æ¸¬çµæœæ­£ç¢º
2. **Software Verificationï¼ˆè»Ÿé«”é©—è­‰ï¼‰**ï¼šç¢ºä¿ AI ç¬¦åˆè¦ç¯„
3. **ç‰ˆæœ¬ç®¡ç†**ï¼šæ¯æ¬¡æ›´æ–° AI **éœ€è¨˜éŒ„è®Šæ›´å½±éŸ¿**

---

## **(4) ç¬¦åˆ ISO 14971ï¼ˆé¢¨éšªç®¡ç†ï¼‰**

ğŸ”¹ **AI é¢¨éšªè©•ä¼°**

- AI å¯èƒ½æœƒï¼š
    - **éŒ¯èª¤è¨ºæ–·**ï¼ˆFalse Positive/False Negativeï¼‰
    - **å°ä¸åŒæ‚£è€…æ—ç¾¤æœ‰åè¦‹**
    - **å½±åƒé›œè¨Šå½±éŸ¿ AI æº–ç¢ºæ€§**

ğŸ”¹ **å¦‚ä½•é™ä½é¢¨éšªï¼Ÿ**

- **ä½¿ç”¨å…¬å¹³æ€§æ¸¬è©¦ï¼ˆFairness Testingï¼‰**ï¼š
    - æ¸¬è©¦ AI åœ¨ **ä¸åŒæ€§åˆ¥ã€å¹´é½¡ã€ç¨®æ—** çš„ IVUS å½±åƒä¸Šè¡¨ç¾
- **è¨­è¨ˆ AI ç›£æ§ç³»çµ±ï¼ˆAI Model Monitoringï¼‰**ï¼š
    - è‹¥ AI **æº–ç¢ºç‡ä¸‹é™è¶…é 5%**ï¼Œè§¸ç™¼è­¦å‘Š

ğŸ’¡ **å»ºè­°**ï¼š

- æ¯å€‹ AI æ±ºç­–çµæœ **éœ€æä¾›ä¸ç¢ºå®šæ€§æŒ‡æ¨™**
- ä½¿ç”¨ **XAIï¼ˆå¯è§£é‡‹ AIï¼‰**ï¼Œç¢ºä¿é†«ç”Ÿç†è§£ AI çš„è¨ºæ–·é‚è¼¯

---

# **3. IVUS AI é–‹ç™¼çš„ 5 å€‹é—œéµæ­¥é©Ÿ**

ğŸ”¹ **(1) å»ºç«‹æ¨™æº–åŒ– IVUS è¨“ç·´æ•¸æ“š**

- æ•¸æ“šä¾†è‡ª **å¤šå€‹é†«é™¢ã€å¤šå€‹æƒæå„€**
- **æ¨™è¨»æ¨™æº–åŒ–**ï¼ˆç¢ºä¿é†«ç”Ÿæ¨™è¨»çš„ä¸€è‡´æ€§ï¼‰

ğŸ”¹ **(2) é–‹ç™¼ç¬¦åˆ IEC 62304 çš„ AI æ¨¡å‹**

- ä½¿ç”¨ **PyTorch/TensorFlow + ONNX**ï¼Œç¢ºä¿æ¨¡å‹å¯ç§»æ¤
- è¨­è¨ˆ **Explainable AI (SHAP, Grad-CAM)**ï¼Œç¢ºä¿ AI å¯è§£é‡‹æ€§

ğŸ”¹ **(3) é€²è¡Œ ISO 14971 é¢¨éšªè©•ä¼°**

- ç¢ºä¿ AI **False Positive < 5%**
- ç¢ºä¿ AI **å°æ‰€æœ‰äººç¾¤å…¬å¹³ï¼ˆBias < 1%ï¼‰**

ğŸ”¹ **(4) é€²è¡Œ FDA/MDR ç¬¦åˆæ€§æ¸¬è©¦**

- ä½¿ç”¨ **>500 ä¾‹ IVUS å½±åƒé€²è¡Œé©—è­‰**
- ç¢ºä¿ AI å¯èˆ‡**è‡¨åºŠé†«å¸«è¨ºæ–·çµæœä¸€è‡´**

ğŸ”¹ **(5) éƒ¨ç½² AI ä¸¦é€²è¡Œ Post-Market Surveillance**

- AI åœ¨è‡¨åºŠæ‡‰ç”¨æ™‚ï¼Œè‹¥æº–ç¢ºç‡ä¸‹é™ **>5%**ï¼Œéœ€å›å ±

---

# **4. çµè«–**

1. **IVUS AI å±¬æ–¼é«˜é¢¨éšªé†«ç™‚ AIï¼ˆSaMDï¼‰**ï¼Œéœ€ç¬¦åˆ **FDA 510(k)/PMAã€MDR**
2. **ISO 13485 & IEC 62304 è¦æ±‚** AI **é–‹ç™¼å…¨ç¨‹å¯è¿½æº¯**
3. **ISO 14971 é¢¨éšªè©•ä¼°** æ˜¯æ ¸å¿ƒï¼Œéœ€æ¸¬è©¦ **False Positive, Bias**
4. **ç¢ºä¿ AI å¯è§£é‡‹æ€§ï¼ˆXAIï¼‰**ï¼Œè®“é†«ç”Ÿå¯ç†è§£ AI è¨ºæ–·çµæœ
5. **Post-Market Surveillance** ç›£æ¸¬ AI åœ¨è‡¨åºŠä¸­çš„è¡¨ç¾ï¼Œç¢ºä¿å®‰å…¨æ€§

ğŸš€ **é€™äº›æ³•è¦è¦æ±‚æ˜¯ç¢ºä¿ AI åœ¨é†«ç™‚ç’°å¢ƒä¸­å®‰å…¨éƒ¨ç½²çš„é—œéµ**ï¼




## **IVUS ä¸‰ç¨®å½±åƒåˆ†å‰²æ–¹æ³•åŸç†èˆ‡æ­¥é©Ÿè©³è§£**

åœ¨ IVUSï¼ˆIntravascular Ultrasound, è¡€ç®¡å…§è¶…éŸ³æ³¢ï¼‰å½±åƒåˆ†æä¸­ï¼Œå½±åƒåˆ†å‰²ï¼ˆSegmentationï¼‰æ˜¯é—œéµæ­¥é©Ÿä¹‹ä¸€ï¼Œä¸»è¦ç›®æ¨™æ˜¯è­˜åˆ¥**è¡€ç®¡å…§è…”ï¼ˆLumenï¼‰ã€è¡€ç®¡å£ï¼ˆMedia & External Elastic Lamina, EELï¼‰ã€æ–‘å¡Šï¼ˆPlaqueï¼‰**ç­‰çµæ§‹ã€‚

é€™è£¡è©³ç´°ä»‹ç´¹ **ä¸‰ç¨® IVUS å½±åƒåˆ†å‰²æ–¹æ³•**ï¼ŒåŒ…æ‹¬å…¶**åŸç†ã€æ­¥é©Ÿã€èˆ‡å…·é«”èˆ‰ä¾‹**ã€‚

---

## **1. Direct Border Detectionï¼ˆç›´æ¥é‚Šç•Œæª¢æ¸¬ï¼‰**

### **ğŸ”¹ åŸç†**

- ç›´æ¥åµæ¸¬ IVUS å½±åƒä¸­çš„ **è¡€ç®¡å…§è…”é‚Šç•Œï¼ˆLumen Borderï¼‰** å’Œ **è¡€ç®¡å¤–è†œé‚Šç•Œï¼ˆMedia-External Border, MEBï¼‰**ã€‚
- é€é **æ¢¯åº¦è®ŠåŒ–ã€æ´»æ€§è¼ªå»“æ¨¡å‹ï¼ˆActive Contour Model, ACMï¼‰ã€æ·±åº¦å­¸ç¿’ CNNï¼ˆConvolutional Neural Networkï¼‰** ä¾†é€²è¡Œé‚Šç•Œåµæ¸¬ã€‚

### **ğŸ”¹ æ­¥é©Ÿ**

#### **(1) å½±åƒå‰è™•ç†**

- ä½¿ç”¨ **é«˜æ–¯æ¿¾æ³¢ï¼ˆGaussian Filteringï¼‰** å»é™¤å™ªè²
- æ‡‰ç”¨ **ç›´æ–¹åœ–å‡è¡¡åŒ–ï¼ˆHistogram Equalizationï¼‰** å¢å¼·å°æ¯”åº¦

#### **(2) é‚Šç·£åµæ¸¬**

- **å‚³çµ±æ–¹æ³•**ï¼š
    - Sobel æˆ– Canny é‚Šç·£åµæ¸¬
    - ä½¿ç”¨ **Hough Transform** åµæ¸¬åœ“å½¢çµæ§‹ï¼ˆå‡è¨­è¡€ç®¡å…§è…”ç‚ºåœ“å½¢ï¼‰
- **ä¸»å‹•è¼ªå»“æ¨¡å‹ï¼ˆActive Contour Model, ACMï¼‰**ï¼š
    - é€é Snake Model è®“é‚Šç•Œç·šè‡ªå‹•æ”¶ç¸®è‡³é«˜æ¢¯åº¦å€åŸŸ
    - é€é Level Set æ–¹æ³•æ›´æ–°é‚Šç•Œ

#### **(3) æ·±åº¦å­¸ç¿’æ–¹æ³•**

- **U-Net / DeepLabV3+ CNN**ï¼šè¨“ç·´ AI æ¨¡å‹ä¾†ç›´æ¥å­¸ç¿’ IVUS å…§è…”é‚Šç•Œ
- **Vision Transformer (ViT) + CNN Hybrid**ï¼šæ•æ‰å…¨å±€èˆ‡å±€éƒ¨è³‡è¨Š

### **ğŸ”¹ å…·é«”èˆ‰ä¾‹**

ğŸ’¡ **æ‡‰ç”¨å ´æ™¯**ï¼š

- **è‡ªå‹•åŒ–è¡€ç®¡åˆ†æ**ï¼ˆä¾‹å¦‚ Philips IVUS SyncVisionï¼Œè¼”åŠ©é†«å¸«æ¸¬é‡è¡€ç®¡ç›´å¾‘ï¼‰
- **è¨ºæ–·å‹•è„ˆç‹¹çª„ç¨‹åº¦**ï¼ˆå¦‚è¡€ç®¡å…§è…”é¢ç©ï¼‰

---

## **2. Blood Speckle Noise Reductionï¼ˆè¡€æ¶²æ•£æ–‘å™ªè²æŠ‘åˆ¶ï¼‰**

### **ğŸ”¹ åŸç†**

- IVUS å½±åƒä¸­çš„ **è¡€æ¶²å€åŸŸï¼ˆBlood Poolï¼‰** å—åˆ°è¶…éŸ³æ³¢æ•£å°„æ•ˆæ‡‰ï¼ˆSpeckle Noiseï¼‰å½±éŸ¿ï¼Œå°è‡´å½±åƒæœ‰å¼·çƒˆçš„é»ç‹€é›œè¨Šï¼Œä½¿å¾—å…§è…”é‚Šç•Œé›£ä»¥æº–ç¢ºåˆ†å‰²ã€‚
- **ä½¿ç”¨å½±åƒè™•ç†æŠ€è¡“æˆ– AI ä¾†å»é™¤ Speckle Noiseï¼Œæé«˜å…§è…”èˆ‡è¡€ç®¡å£çš„å°æ¯”åº¦ã€‚**

### **ğŸ”¹ æ­¥é©Ÿ**

#### **(1) å½±åƒé™å™ª**

- **ç©ºé–“åŸŸæ–¹æ³•**ï¼š
    - **éå±€éƒ¨å‡å€¼ï¼ˆNon-Local Means, NLMï¼‰**ï¼šä¿ç•™è¡€ç®¡é‚Šç•Œç´‹ç†
    - **é›™é‚Šæ¿¾æ³¢ï¼ˆBilateral Filterï¼‰**ï¼šå»é™¤å™ªè²ä½†ä¿ç•™é‚Šç•Œè³‡è¨Š
- **é »ç‡åŸŸæ–¹æ³•**ï¼š
    - **å°æ³¢è®Šæ›ï¼ˆWavelet Transformï¼‰**ï¼šé€éä¸åŒå°ºåº¦å»é™¤ Speckle Noise
    - **Gabor æ¿¾æ³¢å™¨**ï¼šå¢å¼·è¡€ç®¡ç´‹ç†

#### **(2) AI å»å™ª**

- **CNNï¼ˆå¦‚ DnCNN, U-Netï¼‰**ï¼šè¨“ç·´ AI ä¾†è­˜åˆ¥ä¸¦å»é™¤ Speckle Noise
- **GANï¼ˆå¦‚ Pix2Pix, CycleGANï¼‰**ï¼šé€éå°æŠ—å­¸ç¿’ç”Ÿæˆå»å™ªå½±åƒ

#### **(3) å¢å¼·å°æ¯”**

- **å±€éƒ¨è‡ªé©æ‡‰ç›´æ–¹åœ–å‡è¡¡åŒ–ï¼ˆCLAHEï¼‰** æé«˜å°æ¯”åº¦
- **éç·šæ€§æ˜ å°„ï¼ˆGamma Correctionï¼‰** å¢å¼·è¡€ç®¡èˆ‡èƒŒæ™¯çš„å€åˆ¥

### **ğŸ”¹ å…·é«”èˆ‰ä¾‹**

ğŸ’¡ **æ‡‰ç”¨å ´æ™¯**ï¼š

- **æ”¯æ¶ç½®æ”¾è©•ä¼°**ï¼ˆå»é™¤è¡€æ¶²å€åŸŸå™ªè²ï¼Œæé«˜æ”¯æ¶å¯è¦–æ€§ï¼‰
- **è¡€æ “åµæ¸¬**ï¼ˆSpeckle Noise å¯èƒ½èˆ‡è¡€æ “ç´‹ç†æ··æ·†ï¼‰

---

## **3. Luminal and Blood Pool Areas Analysisï¼ˆè¡€ç®¡å…§è…”èˆ‡è¡€æ± å€åŸŸåˆ†æï¼‰**

### **ğŸ”¹ åŸç†**

- åˆ†æ **è¡€ç®¡å…§è…”ï¼ˆLumenï¼‰** å’Œ **è¡€æ¶²æ± ï¼ˆBlood Poolï¼‰** é¢ç©ï¼Œä»¥è©•ä¼°å‹•è„ˆç‹¹çª„ç¨‹åº¦èˆ‡è¡€æµå½±éŸ¿ã€‚
- **Luminal Area**ï¼šæŒ‡ IVUS å½±åƒä¸­ **å…§è…”çš„ç¸½é¢ç©**ï¼Œç”¨æ–¼è¨ºæ–·å‹•è„ˆé˜»å¡ç¨‹åº¦ã€‚
- **Blood Pool Area**ï¼šè¡€æ¶²å›è²è¼ƒä½çš„å€åŸŸï¼Œå¯ç”¨ä¾†åµæ¸¬ **è¡€æ “æˆ–ç•°å¸¸è¡€æµ**ã€‚

### **ğŸ”¹ æ­¥é©Ÿ**

#### **(1) å…§è…”å€åŸŸåˆ†å‰²**

- **é–¾å€¼æ³•ï¼ˆThresholdingï¼‰**ï¼š
    - ä½¿ç”¨ Otsuâ€™s Method è¨­å®šè‡ªé©æ‡‰é–¾å€¼ä¾†å€åˆ†è¡€æ¶²èˆ‡è¡€ç®¡å£
- **å€åŸŸç”Ÿé•·æ³•ï¼ˆRegion Growingï¼‰**ï¼š
    - ä»¥é«˜å¼·åº¦åƒç´ ä½œç‚ºç¨®å­é»ï¼Œå‘å¤–æ“´å±•å€åŸŸ
- **K-means / GMMï¼ˆGaussian Mixture Modelï¼‰**ï¼š
    - ä½¿ç”¨æ©Ÿå™¨å­¸ç¿’åˆ†é¡å½±åƒåƒç´ ï¼Œå€åˆ† **è¡€æ¶² vs. è¡€ç®¡å£**

#### **(2) è¡€æ¶²æ± åˆ†æ**

- **è­˜åˆ¥è¡€æ¶²ä½å›è²å€åŸŸ**
    - æ‡‰ç”¨ **é™°å½±åµæ¸¬ï¼ˆShadow Detectionï¼‰** ä¾†è­˜åˆ¥è¡€æ¶²å€åŸŸ
- **è¡€æµå‹•åŠ›å­¸æ¨¡æ“¬**
    - ä½¿ç”¨ **AI+æ•¸å€¼æµé«”åŠ›å­¸ï¼ˆCFDï¼‰** è¨ˆç®—è¡€æµæ”¹è®Šå°è¡€æ “çš„å½±éŸ¿

#### **(3) è¨ˆç®— Luminal Area**

- é€é **åˆ†å‰²çµæœè¨ˆç®—è¡€ç®¡å…§è…”é¢ç©ï¼ˆmmÂ²ï¼‰**
- æ¯”è¼ƒ **ç‹¹çª„æ®µèˆ‡å¥åº·æ®µçš„ Luminal é¢ç©æ¯”ä¾‹**ï¼Œè¨ºæ–·å‹•è„ˆç‹¹çª„ç¨‹åº¦

### **ğŸ”¹ å…·é«”èˆ‰ä¾‹**

ğŸ’¡ **æ‡‰ç”¨å ´æ™¯**ï¼š

- **è¨ºæ–·å‹•è„ˆç‹¹çª„**ï¼ˆè¡€ç®¡å…§è…”ç‹¹çª„ <4mmÂ² å¯èƒ½æœ‰é«˜é¢¨éšªï¼‰
- **æ”¯æ¶å‰å¾Œè©•ä¼°**ï¼ˆæ”¯æ¶ç½®æ”¾å¾Œå…§è…”é¢ç©è®ŠåŒ–ï¼‰

---

## **ğŸ” ç¸½çµ**

|æ–¹æ³•|ä¸»è¦ç›®çš„|ä¸»è¦æŠ€è¡“|æ‡‰ç”¨å ´æ™¯|
|---|---|---|---|
|**Direct Border Detection**|æª¢æ¸¬è¡€ç®¡å…§è…”èˆ‡è¡€ç®¡å£é‚Šç•Œ|Sobelã€ACMã€CNNï¼ˆU-Net, DeepLabV3+ï¼‰|**è‡ªå‹•æ¸¬é‡è¡€ç®¡ç‹¹çª„ç¨‹åº¦ã€æ–‘å¡Šè©•ä¼°**|
|**Blood Speckle Noise Reduction**|å»é™¤è¡€æ¶²æ•£æ–‘å™ªè²ï¼Œå¢å¼·å½±åƒå°æ¯”åº¦|NLMã€Bilateral Filterã€GANï¼ˆPix2Pixï¼‰|**æé«˜æ”¯æ¶å½±åƒå¯è¦–æ€§ã€è¨ºæ–·è¡€æ “**|
|**Luminal and Blood Pool Areas Analysis**|è¨ˆç®—è¡€ç®¡å…§è…”é¢ç©ï¼Œè©•ä¼°è¡€æµé˜»åŠ›|Otsuâ€™s é–¾å€¼ã€GMMã€CFD|**è¨ºæ–·å† ç‹€å‹•è„ˆç–¾ç—…ã€åˆ†æè¡€æ “**|

é€™ä¸‰ç¨®æ–¹æ³•äº’ç›¸è£œå……ï¼Œèƒ½æœ‰æ•ˆæå‡ **IVUS AI å½±åƒåˆ†å‰²çš„æº–ç¢ºæ€§èˆ‡è‡¨åºŠæ‡‰ç”¨åƒ¹å€¼** ğŸš€ï¼

## **4. çµè«–**

è©²è·ä½ä¸»è¦ç¢ºä¿æ©Ÿå™¨å­¸ç¿’æŠ€è¡“ç¬¦åˆ**é†«ç™‚æ³•è¦æ¨™æº–**ï¼Œä¸¦é€²è¡Œé¢¨éšªè©•ä¼°èˆ‡æ¸›è¼•é¢¨éšªã€‚é€™æ„å‘³è‘— **ä¸åƒ…è¦å…·å‚™ AI/ML æŠ€è¡“ï¼Œä¹Ÿéœ€è¦ç†è§£é†«ç™‚æ³•è¦èˆ‡é¢¨éšªç®¡ç†**ï¼Œå°¤å…¶æ˜¯åœ¨**é–‹ç™¼èˆ‡éƒ¨ç½²éç¨‹ä¸­å¦‚ä½•ç¢ºä¿ AI å®‰å…¨æ€§èˆ‡å…¬å¹³æ€§**ã€‚






åœ¨ **IVUSï¼ˆè¡€ç®¡å…§è¶…éŸ³æ³¢ï¼‰å½±åƒ** åˆ†æä¸­ï¼Œåµæ¸¬èˆ‡å»é™¤ **artifactsï¼ˆå½å½±ï¼‰ã€calcificationï¼ˆéˆ£åŒ–ï¼‰ã€complex calcified lesionsï¼ˆè¤‡é›œéˆ£åŒ–ç—…è®Šï¼‰** æ˜¯æé«˜å½±åƒè³ªé‡èˆ‡è¨ºæ–·æº–ç¢ºæ€§çš„é—œéµæ­¥é©Ÿã€‚ä»¥ä¸‹æ˜¯è©³ç´°ä»‹ç´¹é€™äº›å•é¡Œçš„åµæ¸¬èˆ‡å»é™¤æ–¹æ³•ã€‚

---

## **1. Artifactsï¼ˆå½å½±ï¼‰åµæ¸¬èˆ‡å»é™¤æ–¹æ³•**

### **IVUS ä¸­å¸¸è¦‹å½å½±é¡å‹**

- **Ring-down artifact**ï¼šè¶…éŸ³æ³¢æ¢é ­é™„è¿‘çš„ç’°ç‹€å‡è±¡
- **Shadowing artifact**ï¼šç”±æ–¼éˆ£åŒ–æˆ–å…¶ä»–é«˜åå°„çµæ§‹ç”¢ç”Ÿçš„å½±åƒé®è”½ç¾è±¡
- **Reverberation artifact**ï¼šè¶…éŸ³æ³¢åœ¨é«˜åå°„ç•Œé¢ä¸Šä¾†å›åå°„ç”¢ç”Ÿçš„å¤šé‡å›æ³¢

### **åµæ¸¬èˆ‡å»é™¤æ–¹æ³•**

#### **(1) å½±åƒè™•ç†æ–¹æ³•**

- **é »ç‡åŸŸåˆ†æï¼ˆFrequency Analysisï¼‰**ï¼š
    
    - æ‡‰ç”¨ **FFTï¼ˆå¿«é€Ÿå‚…ç«‹è‘‰è½‰æ›ï¼‰** åˆ†æå½å½±é »ç‡æˆåˆ†ï¼Œä¸¦é€²è¡Œæ¿¾æ³¢å»é™¤ã€‚
    - **é«˜é€šæ¿¾æ³¢å™¨** å¯å»é™¤ä½é »æˆåˆ†ï¼Œå¦‚ **ring-down artifact**ã€‚
- **ç©ºé–“åŸŸæ¿¾æ³¢**ï¼š
    
    - **å‡å€¼æ¿¾æ³¢ï¼ˆMean Filteringï¼‰** å»é™¤å°å‹å½å½±ï¼Œä½†å¯èƒ½é™ä½ç´°ç¯€æ¸…æ™°åº¦ã€‚
    - **ä¸­å€¼æ¿¾æ³¢ï¼ˆMedian Filteringï¼‰** å¯æœ‰æ•ˆå»é™¤ **speckle noiseï¼ˆæ•£æ–‘å™ªè²ï¼‰**ï¼Œä¿ç•™é‚Šç•Œç´°ç¯€ã€‚
- **å½¢æ…‹å­¸è™•ç†ï¼ˆMorphological Processingï¼‰**ï¼š
    
    - ä½¿ç”¨å½¢æ…‹å­¸é–‹é‹ç®—ï¼ˆOpeningï¼‰å»é™¤äº®é»å½å½±ï¼ˆå¦‚å°å‹éˆ£åŒ–æˆ–é›œè¨Šï¼‰ã€‚

#### **(2) AI å»å½å½±æ–¹æ³•**

- **å·ç©ç¥ç¶“ç¶²çµ¡ï¼ˆCNNï¼‰**ï¼š
    - ä½¿ç”¨ **U-Net** æˆ– **DeepLabV3+** è‡ªå‹•è­˜åˆ¥ä¸¦å»é™¤å½å½±ã€‚
- **ç”Ÿæˆå°æŠ—ç¶²çµ¡ï¼ˆGANï¼‰**ï¼š
    - å¦‚ **Pix2Pix** å¯ç”¨æ–¼å½±åƒå¢å¼·ï¼Œå°‡å¸¶æœ‰å½å½±çš„ IVUS å½±åƒè½‰æ›æˆç„¡å½å½±ç‰ˆæœ¬ã€‚

#### **å…·é«”èˆ‰ä¾‹**

- åœ¨è™•ç† **ring-down artifact** æ™‚ï¼Œä½¿ç”¨ **FFT é«˜é€šæ¿¾æ³¢å™¨** å¯æœ‰æ•ˆå»é™¤æ¢é ­é™„è¿‘çš„ä½é »ç’°ç‹€å½å½±ã€‚

---

## **2. Calcificationï¼ˆéˆ£åŒ–ï¼‰åµæ¸¬èˆ‡å»é™¤æ–¹æ³•**

### **IVUS ä¸­éˆ£åŒ–ç‰¹å¾µ**

- éˆ£åŒ–å€åŸŸé€šå¸¸åœ¨ IVUS å½±åƒä¸­è¡¨ç¾ç‚ºé«˜äº®å›è²å€åŸŸï¼Œä¸”ç”¢ç”Ÿ **é™°å½±ï¼ˆacoustic shadowingï¼‰**ï¼Œå½±éŸ¿å°è¡€ç®¡å…§è…”çš„è§€å¯Ÿã€‚

### **åµæ¸¬èˆ‡å»é™¤æ–¹æ³•**

#### **(1) éˆ£åŒ–å€åŸŸåµæ¸¬æ–¹æ³•**

- **é–¾å€¼åˆ†å‰²æ³•ï¼ˆThresholdingï¼‰**ï¼š
    
    - è¨­å®šé«˜äº®åº¦é–¾å€¼ï¼Œå°‡éˆ£åŒ–å€åŸŸèˆ‡èƒŒæ™¯å€åˆ†é–‹ä¾†ã€‚
    - ä½¿ç”¨ **Otsu's Method** è‡ªå‹•é¸æ“‡æœ€ä½³é–¾å€¼ã€‚
- **é‚Šç·£åµæ¸¬æ³•ï¼ˆEdge Detectionï¼‰**ï¼š
    
    - ä½¿ç”¨ **Sobel æˆ– Canny é‚Šç·£åµæ¸¬** æå–éˆ£åŒ–é‚Šç•Œã€‚
- **æ©Ÿå™¨å­¸ç¿’æ–¹æ³•**ï¼š
    
    - ä½¿ç”¨ **SVMï¼ˆæ”¯æŒå‘é‡æ©Ÿï¼‰** æ ¹æ“šäº®åº¦èˆ‡ç´‹ç†ç‰¹å¾µåˆ†é¡éˆ£åŒ–å€åŸŸã€‚
- **æ·±åº¦å­¸ç¿’æ–¹æ³•**ï¼š
    
    - ä½¿ç”¨ **ResNetã€U-Net æˆ– SegNet** è‡ªå‹•åˆ†å‰²éˆ£åŒ–å€åŸŸã€‚
    - **Hybrid CNN-LSTM** æ¨¡å‹æ•æ‰æ™‚é–“åºåˆ—ä¸­çš„éˆ£åŒ–è®ŠåŒ–ã€‚

#### **(2) éˆ£åŒ–å€åŸŸå»é™¤æˆ–é™ä½å½±éŸ¿**

- **é™°å½±è£œå„ŸæŠ€è¡“ï¼ˆShadow Compensationï¼‰**ï¼š
    
    - ä½¿ç”¨ **åæŠ•å½±æ¼”ç®—æ³•ï¼ˆBack-Projection Algorithmï¼‰** æ¸›å°‘éˆ£åŒ–é™°å½±æ•ˆæ‡‰ã€‚
- **å½±åƒèåˆæŠ€è¡“**ï¼š
    
    - å°‡ IVUS èˆ‡ **OCTï¼ˆOptical Coherence Tomographyï¼‰** å½±åƒçµåˆï¼Œæé«˜è¨ºæ–·æº–ç¢ºåº¦ã€‚
- **å½±åƒå¢å¼·æŠ€è¡“ï¼ˆImage Enhancementï¼‰**ï¼š
    
    - ä½¿ç”¨ **CLAHEï¼ˆè‡ªé©æ‡‰ç›´æ–¹åœ–å‡è¡¡åŒ–ï¼‰** æé«˜ééˆ£åŒ–å€åŸŸçš„å°æ¯”åº¦ã€‚

#### **å…·é«”èˆ‰ä¾‹**

- å° IVUS å½±åƒé€²è¡Œ **Sobel é‚Šç·£åµæ¸¬**ï¼Œæå–éˆ£åŒ–é‚Šç•Œï¼Œç„¶å¾Œä½¿ç”¨ **CLAHE å¢å¼·å½±åƒ** ä¾†é™ä½éˆ£åŒ–é™°å½±å½±éŸ¿ã€‚

---

## **3. Complex Calcified Lesionsï¼ˆè¤‡é›œéˆ£åŒ–ç—…è®Šï¼‰åµæ¸¬èˆ‡åˆ†ææ–¹æ³•**

### **è¤‡é›œéˆ£åŒ–ç—…è®Šç‰¹å¾µ**

- åœ¨ IVUS å½±åƒä¸­ï¼Œè¤‡é›œéˆ£åŒ–ç—…è®Šé€šå¸¸å…·æœ‰å¤šå±¤çµæ§‹ï¼Œä¸¦ä¼´éš¨é¡¯è‘—çš„é™°å½±é®è”½æ•ˆæ‡‰ï¼Œå¯èƒ½å°è‡´å‹•è„ˆç‹¹çª„æˆ–æ”¯æ¶æ“´å¼µå›°é›£ã€‚

### **åµæ¸¬èˆ‡åˆ†ææ–¹æ³•**

#### **(1) è¤‡é›œéˆ£åŒ–ç—…è®Šåµæ¸¬æ–¹æ³•**

- **å¤šå°ºåº¦å½±åƒåˆ†æï¼ˆMultiscale Image Analysisï¼‰**ï¼š
    - ä½¿ç”¨ **å°æ³¢è®Šæ›ï¼ˆWavelet Transformï¼‰** åˆ†æä¸åŒå°ºåº¦ä¸‹çš„éˆ£åŒ–çµæ§‹ã€‚
- **æ–‘å¡Šåˆ†é¡æ–¹æ³•ï¼ˆPlaque Classificationï¼‰**ï¼š
    - ä½¿ç”¨ **K-means èšé¡** æˆ– **GMMï¼ˆé«˜æ–¯æ··åˆæ¨¡å‹ï¼‰** å°‡å½±åƒåˆ†ç‚º **éˆ£åŒ–ã€çº–ç¶­ã€è„‚è³ª** ç­‰é¡å‹ã€‚
- **æ·±åº¦å­¸ç¿’æ–¹æ³•**ï¼š
    - ä½¿ç”¨ **3D CNN æˆ– Hybrid CNN+RNN** æ¨¡å‹ï¼Œè‡ªå‹•è­˜åˆ¥è¤‡é›œéˆ£åŒ–ç—…è®Šçš„ç©ºé–“çµæ§‹ã€‚

#### **(2) è¤‡é›œéˆ£åŒ–ç—…è®Šå°ç­–**

- **éˆ£åŒ–å½±åƒå¢å¼·**ï¼š
    - ä½¿ç”¨ **å½±åƒå»å™ªï¼ˆå¦‚ Bilateral Filterï¼‰** æé«˜éˆ£åŒ–å€åŸŸæ¸…æ™°åº¦ã€‚
- **è¼”åŠ©è¨ºæ–·ç³»çµ±ï¼ˆCADï¼‰**ï¼š
    - é–‹ç™¼åŸºæ–¼ AI çš„ **è¼”åŠ©è¨ºæ–·ç³»çµ±**ï¼Œå³æ™‚æä¾›è¤‡é›œéˆ£åŒ–ç—…è®Šçš„é¢¨éšªè©•ä¼°å ±å‘Šã€‚

#### **å…·é«”èˆ‰ä¾‹**

- ä½¿ç”¨ **3D CNN** æ¨¡å‹è‡ªå‹•è­˜åˆ¥ IVUS å½±åƒä¸­çš„ **è¤‡é›œéˆ£åŒ–ç—…è®Š**ï¼Œä¸¦æä¾›æ¯å€‹ç—…è®Šä½ç½®çš„è¨ºæ–·åˆ†æ•¸ã€‚

---

## **ç¸½çµèˆ‡å»ºè­°**

|å•é¡Œé¡å‹|åµæ¸¬æŠ€è¡“|å»é™¤æˆ–æ¸›å°‘å½±éŸ¿æŠ€è¡“|æ‡‰ç”¨å ´æ™¯|
|---|---|---|---|
|**Artifactsï¼ˆå½å½±ï¼‰**|FFTã€å½¢æ…‹å­¸è™•ç†ã€GAN|é«˜é€šæ¿¾æ³¢ã€å½¢æ…‹å­¸é‹ç®—ã€GAN å¢å¼·|æé«˜å½±åƒè³ªé‡ï¼Œæ¸›å°‘è¨ºæ–·å¹²æ“¾|
|**Calcificationï¼ˆéˆ£åŒ–ï¼‰**|é–¾å€¼åˆ†å‰²ã€SVMã€U-Net|é™°å½±è£œå„Ÿã€CLAHE å¢å¼·|è¨ºæ–·å‹•è„ˆéˆ£åŒ–ç‹¹çª„ã€è¼”åŠ©æ”¯æ¶è©•ä¼°|
|**Complex Calcified Lesionsï¼ˆè¤‡é›œéˆ£åŒ–ç—…è®Šï¼‰**|å¤šå°ºåº¦åˆ†æã€3D CNN|å½±åƒå¢å¼·ã€AI CAD åˆ†æ|è©•ä¼°å‹•è„ˆç‹¹çª„é¢¨éšªã€æ”¯æ¶è¼”åŠ©æ¤å…¥|

é€™äº›æ–¹æ³•èƒ½å¤ æœ‰æ•ˆæå‡ **IVUS AI æ¨¡å‹** åœ¨**éˆ£åŒ–èˆ‡å½å½±è™•ç†**ä¸Šçš„æº–ç¢ºæ€§èˆ‡ç©©å®šæ€§ï¼Œå¾è€Œæé«˜è‡¨åºŠè¨ºæ–·çš„å¯é æ€§ ğŸš€ï¼



Papers:
[1] https://pubmed.ncbi.nlm.nih.gov/34351974/
Shinohara, Hiroki, et al. "Automatic detection of vessel structure by deep learning using intravascular ultrasound images of the coronary arteries."Â _Plos one_Â 16.8 (2021): e0255577.

[2] https://link.springer.com/article/10.1007/s13239-023-00654-6
Arora, Priyanka, et al. "A state-of-the-art review on coronary artery border segmentation algorithms for intravascular ultrasound (IVUS) images."Â _Cardiovascular Engineering and Technology_Â 14.2 (2023): 264-295.

[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC10685628/
Dong, Liang, et al. "Comparison of deep learning-based image segmentation methods for intravascular ultrasound on retrospective and large image cohort study."Â _BioMedical Engineering OnLine_Â 22.1 (2023): 111.

[4]https://www.sciencedirect.com/science/article/abs/pii/S0895611113001298
Balocco, Simone, et al. "Standardized evaluation methodology and reference database for evaluating IVUS image segmentation."Â _Computerized medical imaging and graphics_Â 38.2 (2014): 70-90.




Dataset and github
[1] https://github.com/Kulbear/ivus-segmentation-icsm2018
IVUS Image Segmentation - ICSM 2018

[2]https://insilico.world/datasets/
éš¸å±¬æ–¼In Silico Worldè¨ˆç•«çš„StentValidæ•¸æ“šåº«ï¼ˆ[https://insilico.world/datasets/ï¼‰æä¾›æ”¯æ¶ç½®å…¥å¾Œå³æ™‚èˆ‡6å€‹æœˆè¿½è¹¤çš„å† ç‹€å‹•è„ˆå¹¾ä½•è³‡è¨Šï¼ŒåŒ…å«ç®¡è…”èˆ‡è¡€ç®¡å£çš„é«˜è§£æåº¦IVUSå½±åƒ](https://insilico.world/datasets/%EF%BC%89%E6%8F%90%E4%BE%9B%E6%94%AF%E6%9E%B6%E7%BD%AE%E5%85%A5%E5%BE%8C%E5%8D%B3%E6%99%82%E8%88%876%E5%80%8B%E6%9C%88%E8%BF%BD%E8%B9%A4%E7%9A%84%E5%86%A0%E7%8B%80%E5%8B%95%E8%84%88%E5%B9%BE%E4%BD%95%E8%B3%87%E8%A8%8A%EF%BC%8C%E5%8C%85%E5%90%AB%E7%AE%A1%E8%85%94%E8%88%87%E8%A1%80%E7%AE%A1%E5%A3%81%E7%9A%84%E9%AB%98%E8%A7%A3%E6%9E%90%E5%BA%A6IVUS%E5%BD%B1%E5%83%8F)[7](https://insilico.world/datasets/)ã€‚è©²æ•¸æ“šé›†ç‰¹åˆ¥é‡å°æ”¯æ¶å…§å†ç‹¹çª„ç¾è±¡è¨­è¨ˆï¼ŒåŒ…å«å®Œæ•´çš„ä¸‰ç¶­è¡€ç®¡é‡å»ºæ•¸æ“šèˆ‡è¡€æµå‹•åŠ›å­¸åƒæ•¸ï¼Œé©ç”¨æ–¼é•·æœŸç™‚æ•ˆè©•ä¼°æ¨¡å‹çš„é–‹ç™¼ã€‚

[3]

Website:
[1] https://www.sozocardiology.com/heart-treatments/intra-vascular-ultrasound-ivus-study/

[2] https://thoracickey.com/intravascular-ultrasound-2/

[3] 